Atherothrombosis and Vascular Biology Group

• 
  Head of Laboratory
  Professor Karlheinz Peter Peter

  karlheinz.peter@baker.edu.au

  View researcher's webpage

  +61 3 8532 1490

Research Overview

Our group pursues a broad range of projects that have a common focus on improving diagnosis and therapy of thrombotic and inflammatory diseases such as myocardial infarction and atherosclerosis. A range of biotechnological methods is used, including recombinant protein design/production, generation of functionalised nanoparticles/liposomes/microbubbles, various omics technologies (single-cell RNA sequencing, proteomics, lipidomics), various immunological technologies, flow cytometry, flow chamber, microfluidics, intravital microscopy, ultrasound, MRI, PET, various fluorescence imaging systems and various animal models of thrombosis, atherosclerosis (including a unique mouse model of plaque instability) and inflammation. Most recently, we have extended our research into the development of mRNA therapeutics.

All of these projects have a strong translational orientation, which is facilitated by several laboratory members (physicians/cardiologists/haematologists) treating patients with cardiovascular and haematological diseases as well as cancer. Several of our research projects resulted in patents and the establishment of start-up companies (e.g., NIRTEK).

Work in the laboratory is particularly attractive for students and postdoctoral researchers who are interested in the development of advanced biotechnological tools for molecular imaging and novel therapeutics (e.g., nanoparticles, anti-inflammatory drugs and mRNA therapeutics for plaque stabilisation). The translational direction of the laboratory and the inclusion of patients in studies is highly attractive for physician scientists.

Research focus

• Molecular imaging of thrombosis and inflammation using MRI, PET, ultrasound, FLECT, and IVIS.
• Novel recombinant therapeutics for thrombotic and inflammatory diseases.
• Microfluidic flow chambers.
• Intravital microscopy.
• Flow cytometry.
• Animal models of thrombosis and inflammation.
• Production of recombinant proteins for diagnosis and therapy.
• Diagnosis and treatment of patients with coronary artery disease and myocardial infarction
• Single-cell RNA sequencing
• mRNA therapeutics for cardiovascular diseases

Staff

Professor Karlheinz Peter & Dr Xiaowei Wang, Lab Heads

Dr James McFadyen, Postdoctoral Researcher

Dr Jonathan Noonan, Postdoctoral Researcher

Dr Mitchell Moon, Postdoctoral Researcher

Dr Aidan Walsh, Postdoctoral Researcher

Dr Cuong Pham, Postdoctoral Researcher

Dr Lisa Domke, Postdoctoral Researcher

Dr Marcel Michla, Postdoctoral Researcher

Dr Mark Vidallon, Postdoctoral Researcher

Dr Ahmed Refaat, Postdoctoral Researcher

Dr Anna Watson, Postdoctoral Researcher

Dr Alex Peh, Postdoctoral Researcher

Dr Hung Nguyen, Postdoctoral Researcher

Ms Viktoria Rose Bongcaron, Research Assistant

Prerna Sharma, Research Assistant

Angela Huang, , PhD student, Research Assistant

Anastasia Barbaro-Wahl, Research Assistant

Yilu Huang, Research Assistant

Dr Hannah Stevens, PhD student

Dr Nalin Dayawansa, PhD student

Yuyang Song, PhD student

Julia Skoraczynski, PhD student

Shania Anggita Prijaya, PhD student

Haikun Liu, PhD student

Runali Patil, PhD student

Abhishek Roy, PhD student

Zhengyuan (Uno) Liu, PhD student

Hew Cheng (Samantha) Loong, PhD student

Chaya Wickramarathne, PhD student

Thomas Montibeller, PhD student

Collaborators

A/Prof Sara Baratchi, Lab Head, UoM and Baker Heart and Diabetes Institute
Prof Alex Bobik, Lab Head, Baker Heart and Diabetes Institute
Prof Harshal Nandurkar, Head of Haemtology, Alfred Hospital and Head of the Australian Centre of Blood Diseases
Prof Michael Parker, Lab Head and Director, Bio21
Prof Steffen Eisenhardt, Deputy Director and Lab Head, Plastic Surgery, University of Freiburg, Germany
Prof Elliot Chaikof, Surgeon-in-Chief, Chairman of Surgery, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, USA
Prof Mark Hulett, Head of the Department of Biochemisty and Genetics, La Trobe University
Dr Jacquie Orian, Lab Head, La Trobe University
Prof Philipp Diehl, Lab Head and Cardiology Consultant, University of Freiburg, Germany
Prof Constantin von zur Muehlen, Deputy Director, Department of Cardiology, University of Freiburg, Germany
A/Prof Dennis Wolf, Lab Head and Cardiology Consultant, University of Freiburg, Germany
Prof Andreas Zirlik, Director of Cardiology, University of Graz, Germany

Funding

National Health and Medical Research Council (NHMRC)

MRFF

National Heart Foundation

CASS Foundation

Philanthropic and commercial funding

Research Outcomes

Publications

Lehmann, M., K. G. Petersen, A. N. Khalaf, D. Haussinger, C. Buchner, M. Sellinger and K. Peter (1990). "Improvement of the exercise capacity of a patient with primary orthostatic hypotension (primary sympathetic insufficiency) by programmed subcutaneous noradrenaline administration via microdosing pump." Klin Wochenschr 68(17): 873.

Bode, C., K. Peter, W. Kübler and H. A. Katus (1994). "[Aggressive thrombolytic therapy of myocardial infarct--limits and possibilities]." Zeitschrift Fur Kardiologie 83(6): 393-403.

O'Toole, T. E., Y. Katagiri, R. J. Faull, K. Peter, R. Tamura, V. Quaranta, J. C. Loftus, S. J. Shattil and M. H. Ginsberg (1994). "Integrin cytoplasmic domains mediate inside-out signal transduction." J Cell Biol 124(6): 1047-1059.

Conzen, P. and K. Peter (1995). "Inhalation anaesthesia at the extremes of age: geriatric anaesthesia." Anaesthesia 50 Suppl: 29-33.

Peter, K. and T. E. O'Toole (1995). "Modulation of cell adhesion by changes in alpha L beta 2 (LFA-1, CD11a/CD18) cytoplasmic domain/cytoskeleton interaction." J Exp Med 181(1): 315-326.

Schwender, D., P. Conzen, S. Klasing, U. Finsterer, E. Poppel and K. Peter (1995). "The effects of anesthesia with increasing end-expiratory concentrations of sevoflurane on midlatency auditory evoked potentials." Anesth Analg 81(4): 817-822.

Bode, C., T. K. Nordt, K. Peter, R. W. Smalling, M. S. Runge and W. Kübler (1996). "Patency trials with reteplase (r-PA): what do they tell us?" The American Journal of Cardiology 78(12A): 16-19.

Peter, K. and C. Bode (1996). "A deletion in the alpha subunit locks platelet integrin alpha IIb beta 3 into a high affinity state." Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis 7(2): 233-236.

Bode, C., Moser, M., Ruef, J., Nordt, T., Peter, K., Kubler, W. & Smalling, R (1997). "Clinical studies with reteplase." DRUGS OF TODAY 33(9): 649-653.

Bode, C., K. Peter, T. Nordt, B. Kohler, M. Moser, J. Ruef and M. S. Runge (1997). "New developments in thrombolytic therapy." Fibrinolysis and Proteolysis 11: 109-114.

Bode, C., K. Peter, T. K. Nordt, J. Ruef, R. W. Smalling and W. Kübler (1997). "Pharmacology and clinical efficacy of reteplase." Fibrinolysis and Proteolysis 11: 29-33.

Nordt, T. K., K. Kornas, K. Peter, S. Fujii, B. E. Sobel, W. Kubler and C. Bode (1997). "Attenuation by gemfibrozil of expression of plasminogen activator inhibitor type 1 induced by insulin and its precursors." Circulation 95(3): 677-683.

Nordt, T. K., K. Peter, W. Kübler and C. Bode (1997). "Regulation of the synthesis of plasminogen activator inhibitor type 1 (PAI-1): pathogenetic mechanism of atherosclerosis in diabetes mellitus?" Fibrinolysis and Proteolysis 11: 141-147.

Peter, K., P. Nawroth, C. Conradt, T. Nordt, T. Weiss, M. Boehme, A. Wunsch, J. Allenberg, W. Kubler and C. Bode (1997). "Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin." Arterioscler Thromb Vasc Biol 17(3): 505-512.

Peter, K., T. Nordt and C. Bode (1997). "Construction of an activated, high-affinity GP IIb/IIIa (αIIbβ3) integrin receptor and its use for the determination of the role of affinity and cytoskeletal anchorage in cell adhesion, cell migration and fibronectin matrix assembly." Fibrinolysis and Proteolysis 11: 193-196.

Gries, A., C. Bode, K. Peter, A. Herr, H. Bohrer, J. Motsch and E. Martin (1998). "Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo." Circulation 97(15): 1481-1487.

Nordt, T. K., M. Moser, B. Kohler, J. Ruef, K. Peter, W. Kübler and C. Bode (1998). "Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction." Thrombosis and Haemostasis 80(6): 881-886.

Peter, K., M. Schwarz, J. Ylänne, B. Kohler, M. Moser, T. Nordt, P. Salbach, W. Kübler and C. Bode (1998). "Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors." Blood 92(9): 3240-3249.

Gries, A., C. Bode, S. Gross, K. Peter, H. Bohrer and E. Martin (1999). "The effect of intravenously administered magnesium on platelet function in patients after cardiac surgery." Anesth Analg 88(6): 1213-1219.

Kaapa, A., K. Peter and J. Ylanne (1999). "Effects of mutations in the cytoplasmic domain of integrin beta(1) to talin binding and cell spreading." Exp Cell Res 250(2): 524-534.

Moser, M., T. Nordt, K. Peter, J. Ruef, B. Kohler, M. Schmittner, R. Smalling, W. Kubler and C. Bode (1999). "Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase." Circulation 100(18): 1858-1864.

Nordt, T. K., K. Peter, J. Ruef, W. Kubler and C. Bode (1999). "Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease." Thromb Haemost 82 Suppl 1: 14-18.

Peter, K., M. Schwarz, C. Conradt, T. Nordt, M. Moser, W. Kubler and C. Bode (1999). "Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18)." Circulation 100(14): 1533-1539.

Peter, K., A. Straub, B. Kohler, M. Volkmann, M. Schwarz, W. Kübler and C. Bode (1999). "Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia." The American Journal of Cardiology 84(5): 519-524.

Peter, K., U. Weirich, T. K. Nordt, J. Ruef and C. Bode (1999). "Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis." Thrombosis and Haemostasis 82 Suppl 1: 38-43.

Ruef, J., T. K. Nordt, K. Peter, M. S. Runge, W. Kubler and C. Bode (1999). "A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregation." Thromb Haemost 82(1): 109-114.

Nordt, T. K., K. Peter, C. Bode and B. E. Sobel (2000). "Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells." J Clin Endocrinol Metab 85(4): 1563-1568.

Peter, K., J. Graeber, S. Kipriyanov, M. Zewe-Welschof, M. S. Runge, W. Kubler, M. Little and C. Bode (2000). "Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa." Circulation 101(10): 1158-1164.

Peter, K., B. Kohler, A. Straub, J. Ruef, M. Moser, T. Nordt, M. Olschewski, M. E. Ohman, W. Kubler and C. Bode (2000). "Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine." Circulation 102(13): 1490-1496.

Yanaka, K., N. Kato and T. Nose (2000). "Heparin also interacts with selectins and modulates the cell adhesion process." Circulation 102(20): E169.

Moser, M., J. Ruef, K. Peter, B. Kohler, D. C. Gulba, N. Paterna, T. Nordt, W. Kübler and C. Bode (2001). "Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activity." Journal of Thrombosis and Thrombolysis 12(2): 165-169.

Nordt, T. K., S. Lutzi, J. Ruef, K. Peter, E. Klar, W. Kubler, B. E. Sobel and C. Bode (2001). "Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells." Thromb Haemost 86(5): 1305-1313.

Nordt, T. K., K. Peter and C. Bode (2001). "[GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct]." Herz 26 Suppl 1: 42-45.

Peter, K., M. Schwarz, T. Nordt and C. Bode (2001). "Intrinsic activating properties of GP IIb/IIIa blockers." Thromb Res 103 Suppl 1: S21-27.

Bertram, U., M. Moser, K. Peter, H. F. Kuecherer, R. Bekeredjian, A. Straub, T. K. Nordt, C. Bode and J. Ruef (2002). "Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: a subgroup analysis from the GUSTO V and FASTER trials." J Thromb Thrombolysis 14(3): 197-203.

Jacobin, M.-J., J. Laroche-Traineau, M. Little, A. Keller, K. Peter, M. Welschof, A. Nurden and G. Clofent-Sanchez (2002). "Human IgG monoclonal anti-alpha(IIb)beta(3)-binding fragments derived from immunized donors using phage display." Journal of Immunology (Baltimore, Md.: 1950) 168(4): 2035-2045.

Peter, K., M. Schwarz and C. Bode (2002). "Activating effects of GPIIb/IIIa blockers: an intrinsic consequence of ligand-mimetic properties." Circulation 105(21): E180-181.

Schwarz, M., T. Nordt, C. Bode and K. Peter (2002). "The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2)." Thrombosis Research 107(3-4): 121-128.

Ahrens, I., K. Peter and C. Bode (2003). "Use of GPIIb/IIIa inhibitors in cardiovascular medicine." Expert Rev Cardiovasc Ther 1(2): 233-242.

Conzen, P. F., S. Fischer, C. Detter and K. Peter (2003). "Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery." Anesthesiology 99(4): 826-833.

Decker, M., U. Weirich, T. Nordt, S. Bauer, J. Kreuzer, C. Bode and K. Peter (2003). "Transfection with DNA of soluble VCAM-1 causes monocyte chemotaxis and increased endothelial cell staining: A new gene-therapeutic approach for angiogenesis?" Journal of the American College of Cardiology 41(6, Supplement 1): 298.

Jacobin, M. J., R. Robert, O. Pouns, J. Laroche-Traineau, A. Nurden, K. Peter, M. Little and G. Clofent-Sanchez (2003). "Improving selection of alphaIIbbeta3-binding phage antibodies with increased reactivity derived from immunized donors." Clin Immunol 108(3): 199-210.

Kilger, E., F. Weis, J. Briegel, L. Frey, A. E. Goetz, D. Reuter, A. Nagy, A. Schuetz, P. Lamm, A. Knoll and K. Peter (2003). "Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery." Crit Care Med 31(4): 1068-1074.

Nordt, T. K., E. Eschenfelder, K. Peter, B. E. Sobel and C. Bode (2003). "Independence of growth factor induced plasminogen activator inhibitor type-1 (PAI-1) expression from the 4G/5G polymorphism of the PAI-1 gene." Thromb Haemost 90(1): 36-42.

Peter, K., A. Gupta, T. Nordt, S. Bauer, M. S. Runge and C. Bode (2003). "Construction and in vitro testing of a novel fab-hirudin-based fusion protein that targets fibrin and inhibits thrombin in a factor xa-dependent manner." Journal of Cardiovascular Pharmacology 42(2): 237-244.

Schuler, P., D. Assefa, J. Ylänne, N. Basler, M. Olschewski, I. Ahrens, T. Nordt, C. Bode and K. Peter (2003). "Adhesion of monocytes to medical steel as used for vascular stents is mediated by the integrin receptor Mac-1 (CD11b/CD18; alphaM beta2) and can be inhibited by semiconductor coating." Cell Communication & Adhesion 10(1): 17-26.

Grotz, W., S. Siebig, M. Olschewski, C. W. Strey and K. Peter (2004). "Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation." Transplantation 77(12): 1848-1853.

Hagemeyer, C. E., I. Tomic, U. Weirich, J. Graeber, T. Nordt, M. S. Runge, C. Bode and K. Peter (2004). "Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase." J Thromb Haemost 2(5): 797-803.

Hagemeyer, C. E., I. Tomic, P. Jaminet, U. Weirich, N. Bassler, M. Schwarz, M. S. Runge, C. Bode and K. Peter (2004). "Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide." Thromb Haemost 92(1): 47-53.

Kanse, S. M., R. L. Matz, K. T. Preissner and K. Peter (2004). "Promotion of leukocyte adhesion by a novel interaction between vitronectin and the beta2 integrin Mac-1 (alphaMbeta2, CD11b/CD18)." Arterioscler Thromb Vasc Biol 24(12): 2251-2256.

Peter, K., I. Ahrens, M. Schwarz, C. Bode and J. Ylanne (2004). "Distinct roles of ligand affinity and cytoskeletal anchorage in alphaIIbbeta3 (GP IIb/IIIa)-mediated cell aggregation and adhesion." Platelets 15(7): 427-438.

Peter, K. and C. Bode (2004). "Pharmacotherapy in cardiovascular diseases and vascular interventions." Thromb Haemost 92(6): 1172-1174.

Schwarz, M., Y. Katagiri, M. Kotani, N. Bassler, C. Loeffler, C. Bode and K. Peter (2004). "Reversibility versus persistence of GPIIb/IIIa blocker-induced conformational change of GPIIb/IIIa (alphaIIbbeta3, CD41/CD61)." J Pharmacol Exp Ther 308(3): 1002-1011.

Schwarz, M., P. Rottgen, Y. Takada, F. Le Gall, S. Knackmuss, N. Bassler, C. Buttner, M. Little, C. Bode and K. Peter (2004). "Single-chain antibodies for the conformation-specific blockade of activated platelet integrin alphaIIbbeta3 designed by subtractive selection from naive human phage libraries." FASEB J 18(14): 1704-1706.

Ahrens, I., C. Bode and K. Peter (2005). "Inhibition of platelet activation and aggregation." Handb Exp Pharmacol(170): 443-462.

Huber, R., M. Nauck, N. Basler, B. Haas, M. Mattern, R. Ludtke and K. Peter (2005). "Effects of subtotal fasting on plasmatic coagulation, fibrinolytic status and platelet activation: a controlled pilot study in healthy subjects." Nutr Metab Cardiovasc Dis 15(3): 212-218.

Luzardo-Alvarez, A., N. Blarer, K. Peter, J. F. Romero, C. Reymond, G. Corradin and B. Gander (2005). "Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice." J Control Release 109(1-3): 62-76.

Ahrens, I. G., N. Moran, K. Aylward, G. Meade, M. Moser, D. Assefa, D. J. Fitzgerald, C. Bode and K. Peter (2006). "Evidence for a differential functional regulation of the two beta(3)-integrins alpha(V)beta(3) and alpha(IIb)beta(3)." Exp Cell Res 312(6): 925-937.

Kaufmann, I., A. Hoelzl, F. Schliephake, T. Hummel, A. Chouker, K. Peter and M. Thiel (2006). "Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity." Shock 26(3): 254-261.

Schwarz, M., G. Meade, P. Stoll, J. Ylanne, N. Bassler, Y. C. Chen, C. E. Hagemeyer, I. Ahrens, N. Moran, D. Kenny, D. Fitzgerald, C. Bode and K. Peter (2006). "Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets." Circ Res 99(1): 25-33.

von zur Muhlen, C., K. Peter, J. Spreer, F. Beyersdorf, G. Pache, C. Bode and M. Handke (2006). "Evidence of a steal phenomenon by a thoracic side branch of an internal mammary artery bypass." J Vasc Interv Radiol 17(10): 1714-1715.

Ahrens, I., B. K. Smith, C. Bode and K. Peter (2007). "Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology." Expert Opin Drug Metab Toxicol 3(4): 609-620.

Ahrens, I., K. Peter and C. Bode (2007). "[Factor Xa-inhibition in interventional cardiology]." Hamostaseologie 27(5): 328-332.

Ahrens, I., M. Schwarz, K. Peter and C. Bode (2007). "Therapeutic Inhibitors of Platelet Aggregation – from Aspirin to Integrin Blockersf." Transfusion Medicine and Hemotherapy 34(1): 44-54.

Bassler, N., C. Loeffler, P. Mangin, Y. Yuan, M. Schwarz, C. E. Hagemeyer, S. U. Eisenhardt, I. Ahrens, C. Bode, S. P. Jackson and K. Peter (2007). "A mechanistic model for paradoxical platelet activation by ligand-mimetic alphaIIb beta3 (GPIIb/IIIa) antagonists." Arterioscler Thromb Vasc Biol 27(3): e9-15.

Eisenhardt, S. U., M. Schwarz, N. Schallner, J. Soosairajah, N. Bassler, D. Huang, C. Bode and K. Peter (2007). "Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents." Blood 109(8): 3521-3528.

Eisenhardt, S. U., M. Schwarz, N. Bassler and K. Peter (2007). "Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules." Nat Protoc 2(12): 3063-3073.

Hagemeyer, C. E., M. Schwarz and K. Peter (2007). "Single-chain antibodies as new antithrombotic drugs." Semin Thromb Hemost 33(2): 185-195.

Kaufmann, I., A. Hoelzl, F. Schliephake, T. Hummel, A. Chouker, L. Lysenko, K. Peter and M. Thiel (2007). "Effects of adenosine on functions of polymorphonuclear leukocytes from patients with septic shock." Shock 27(1): 25-31.

Mischak, H., R. Apweiler, R. E. Banks, M. Conaway, J. Coon, A. Dominiczak, J. H. Ehrich, D. Fliser, M. Girolami, H. Hermjakob, D. Hochstrasser, J. Jankowski, B. A. Julian, W. Kolch, Z. A. Massy, C. Neusuess, J. Novak, K. Peter, K. Rossing, J. Schanstra, O. J. Semmes, D. Theodorescu, V. Thongboonkerd, E. M. Weissinger, J. E. Van Eyk and T. Yamamoto (2007). "Clinical proteomics: A need to define the field and to begin to set adequate standards." Proteomics Clin Appl 1(2): 148-156.

Schwarz, M., C. E. Hagemeyer, K. Peter and C. Bode (2007). "[Helping antibodies. Targeted antithrombotic and fibrinolytic therapy]." Hamostaseologie 27(5): 360-362.

Stoll, P., N. Bassler, C. E. Hagemeyer, S. U. Eisenhardt, Y. C. Chen, R. Schmidt, M. Schwarz, I. Ahrens, Y. Katagiri, B. Pannen, C. Bode and K. Peter (2007). "Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation." Arterioscler Thromb Vasc Biol 27(5): 1206-1212.

Straub, A., M. Breuer, H. P. Wendel, K. Peter, K. Dietz and G. Ziemer (2007). "Critical temperature ranges of hypothermia-induced platelet activation: possible implications for cooling patients in cardiac surgery." Thromb Haemost 97(4): 608-616.

von Zur Muhlen, C., D. von Elverfeldt, N. Bassler, I. Neudorfer, B. Steitz, A. Petri-Fink, H. Hofmann, C. Bode and K. Peter (2007). "Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques." Atherosclerosis 193(1): 102-111.

Zirlik, A., C. Maier, N. Gerdes, L. MacFarlane, J. Soosairajah, U. Bavendiek, I. Ahrens, S. Ernst, N. Bassler, A. Missiou, Z. Patko, M. Aikawa, U. Schonbeck, C. Bode, P. Libby and K. Peter (2007). "CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1." Circulation 115(12): 1571-1580.

Ahrens, I. and K. Peter (2008). "Humanizing mouse thrombi." Nat Biotechnol 26(1): 62-63.

Ahrens, I., C. Ellwanger, B. K. Smith, N. Bassler, Y. C. Chen, I. Neudorfer, A. Ludwig, C. Bode and K. Peter (2008). "Selenium supplementation induces metalloproteinase-dependent L-selectin shedding from monocytes." J Leukoc Biol 83(6): 1388-1395.

Ahrens, I. and K. Peter (2008). "Therapeutic integrin inhibition: allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies." Thromb Haemost 99(5): 803-804.

Gwozdz, T., J. Dutko-Gwozdz, V. Zarayskiy, K. Peter and V. M. Bolotina (2008). "How strict is the correlation between STIM1 and Orai1 expression, puncta formation, and ICRAC activation?" Am J Physiol Cell Physiol 295(5): C1133-1140.

Straub, A., H. P. Wendel, K. Dietz, D. Schiebold, K. Peter, S. M. Schoenwaelder and G. Ziemer (2008). "Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation." Thromb Haemost 99(3): 609-615.

von Zur Muhlen, C., N. R. Sibson, K. Peter, S. J. Campbell, P. Wilainam, G. E. Grau, C. Bode, R. P. Choudhury and D. C. Anthony (2008). "A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI." J Clin Invest 118(3): 1198-1207.

von Zur Muhlen, C., D. von Elverfeldt, R. P. Choudhury, J. Ender, I. Ahrens, M. Schwarz, J. Hennig, C. Bode and K. Peter (2008). "Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths." Molecular Imaging 7(2): 59-67.

von zur Muhlen, C., D. von Elverfeldt, J. A. Moeller, R. P. Choudhury, D. Paul, C. E. Hagemeyer, M. Olschewski, A. Becker, I. Neudorfer, N. Bassler, M. Schwarz, C. Bode and K. Peter (2008). "Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis." Circulation 118(3): 258-267.

Woollard, K. J., A. Suhartoyo, E. E. Harris, S. U. Eisenhardt, S. P. Jackson, K. Peter, A. M. Dart, M. J. Hickey and J. P. Chin-Dusting (2008). "Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation." Circ Res 103(10): 1128-1138.

Zimmerli, L. U., E. Schiffer, P. Zurbig, D. M. Good, M. Kellmann, L. Mouls, A. R. Pitt, J. J. Coon, R. E. Schmieder, K. H. Peter, H. Mischak, W. Kolch, C. Delles and A. F. Dominiczak (2008). "Urinary proteomic biomarkers in coronary artery disease." Mol Cell Proteomics 7(2): 290-298.

Ahrens, I. and K. Peter (2009). "FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction." Curr Opin Investig Drugs 10(9): 997-1003.

Eisenhardt, S. U., J. R. Thiele, H. Bannasch, G. B. Stark and K. Peter (2009). "C-reactive protein: how conformational changes influence inflammatory properties." Cell Cycle (Georgetown, Tex.) 8(23): 3885-3892.

Eisenhardt, S. U., J. Habersberger, A. Murphy, Y. C. Chen, K. J. Woollard, N. Bassler, H. Qian, C. von Zur Muhlen, C. E. Hagemeyer, I. Ahrens, J. Chin-Dusting, A. Bobik and K. Peter (2009). "Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques." Circ Res 105(2): 128-137.

Eisenhardt, S. U., J. Habersberger and K. Peter (2009). "Monomeric C-reactive protein generation on activated platelets: the missing link between inflammation and atherothrombotic risk." Trends Cardiovasc Med 19(7): 232-237.

Hagemeyer, C. E. and K. Peter (2009). "Ex-vivo thrombolytic gene therapy for vein graft patency: the frontier for development of selective, localised therapeutic approaches." Thromb Haemost 102(1): 3-4.

Hagemeyer, C. E., C. von Zur Muhlen, D. von Elverfeldt and K. Peter (2009). "Single-chain antibodies as diagnostic tools and therapeutic agents." Thrombosis and Haemostasis 101(6): 1012-1019.

Hu, H., A. Straub, Z. Tian, N. Bassler, J. Cheng and K. Peter (2009). "Celastrol, a triterpene extracted from Tripterygium wilfordii Hook F, inhibits platelet activation." J Cardiovasc Pharmacol 54(3): 240-245.

Khachigian, L. M., K. Peter and M. C. Berndt (2009). "Recent advances in vascular biology: selected highlights from IVBM 2008." Thromb Haemost 101(6): 997-998.

Loffler, C., A. Straub, N. Bassler, K. Pernice, F. Beyersdorf, C. Bode, M. P. Siegenthaler and K. Peter (2009). "Evaluation of platelet activation in patients supported by the Jarvik 2000* high-rotational speed impeller ventricular assist device." J Thorac Cardiovasc Surg 137(3): 736-741.

von Zur Muhlen, C., E. Schiffer, P. Zuerbig, M. Kellmann, M. Brasse, N. Meert, R. C. Vanholder, A. F. Dominiczak, Y. C. Chen, H. Mischak, C. Bode and K. Peter (2009). "Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients." J Proteome Res 8(1): 335-345.

von zur Muhlen, C., K. Peter, Z. A. Ali, J. E. Schneider, M. A. McAteer, S. Neubauer, K. M. Channon, C. Bode and R. P. Choudhury (2009). "Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa." J Vasc Res 46(1): 6-14.

Ahrens, I., G. Y. Lip and K. Peter (2010). "New oral anticoagulant drugs in cardiovascular disease." Thromb Haemost 104(1): 49-60.

Delles, C., E. Schiffer, C. von Zur Muhlen, K. Peter, P. Rossing, H. H. Parving, J. A. Dymott, U. Neisius, L. U. Zimmerli, J. K. Snell-Bergeon, D. M. Maahs, R. E. Schmieder, H. Mischak and A. F. Dominiczak (2010). "Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals." J Hypertens 28(11): 2316-2322.

Good, D. M., P. Zurbig, A. Argiles, H. W. Bauer, G. Behrens, J. J. Coon, M. Dakna, S. Decramer, C. Delles, A. F. Dominiczak, J. H. Ehrich, F. Eitner, D. Fliser, M. Frommberger, A. Ganser, M. A. Girolami, I. Golovko, W. Gwinner, M. Haubitz, S. Herget-Rosenthal, J. Jankowski, H. Jahn, G. Jerums, B. A. Julian, M. Kellmann, V. Kliem, W. Kolch, A. S. Krolewski, M. Luppi, Z. Massy, M. Melter, C. Neususs, J. Novak, K. Peter, K. Rossing, H. Rupprecht, J. P. Schanstra, E. Schiffer, J. U. Stolzenburg, L. Tarnow, D. Theodorescu, V. Thongboonkerd, R. Vanholder, E. M. Weissinger, H. Mischak and P. Schmitt-Kopplin (2010). "Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease." Mol Cell Proteomics 9(11): 2424-2437.

Habersberger, J., S. Eisenhardt and K. Peter (2010). "C-reactive protein measurement and cardiovascular disease." Lancet 375(9720): 1078.

Hagemeyer, C. E., I. Ahrens, N. Bassler, N. Dschachutaschwili, Y. C. Chen, S. U. Eisenhardt, C. Bode and K. Peter (2010). "Genetic transfer of fusion proteins effectively inhibits VCAM-1-mediated cell adhesion and transmigration via inhibition of cytoskeletal anchorage." J Cell Mol Med 14(1-2): 290-302.

Hagemeyer, C. E. and K. Peter (2010). "Targeting the platelet integrin GPIIb/IIIa." Curr Pharm Des 16(37): 4119-4133.

Mischak, H., G. Allmaier, R. Apweiler, T. Attwood, M. Baumann, A. Benigni, S. E. Bennett, R. Bischoff, E. Bongcam-Rudloff, G. Capasso, J. J. Coon, P. D'Haese, A. F. Dominiczak, M. Dakna, H. Dihazi, J. H. Ehrich, P. Fernandez-Llama, D. Fliser, J. Frokiaer, J. Garin, M. Girolami, W. S. Hancock, M. Haubitz, D. Hochstrasser, R. R. Holman, J. P. Ioannidis, J. Jankowski, B. A. Julian, J. B. Klein, W. Kolch, T. Luider, Z. Massy, W. B. Mattes, F. Molina, B. Monsarrat, J. Novak, K. Peter, P. Rossing, M. Sanchez-Carbayo, J. P. Schanstra, O. J. Semmes, G. Spasovski, D. Theodorescu, V. Thongboonkerd, R. Vanholder, T. D. Veenstra, E. Weissinger, T. Yamamoto and A. Vlahou (2010). "Recommendations for biomarker identification and qualification in clinical proteomics." Sci Transl Med 2(46): 46ps42.

Peter, K. and G. Y. Lip (2010). "Changing the scope of preventative and therapeutic approaches in atherothrombosis." Thromb Haemost 103(3): 487-488.

Peter, K. (2010). "Proteomics unravels platelet function." Blood 115(20): 4008-4009.

Peter, K. and G. Y. Lip (2010). "Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy." Thromb Haemost 103(5): 875-876.

Straub, A., J. Smolich, Y. d'Udekem, C. Brizard, K. Peter and S. Horton (2010). "Activation of platelets in young infants during cardiopulmonary bypass." Thromb Haemost 103(2): 466-469.

von zur Muhlen, C., A. Fink-Petri, J. Salaklang, D. Paul, I. Neudorfer, V. Berti, A. Merkle, K. Peter, C. Bode and D. von Elverfeldt (2010). "Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI." Contrast Media Mol Imaging 5(5): 268-275.

Ahrens, I., J. Habersberger, N. Baumlin, H. Qian, B. K. Smith, J. P. Stasch, C. Bode, H. H. Schmidt and K. Peter (2011). "Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free/oxidised sGC." Atherosclerosis 218(2): 431-434.

Ahrens, I., H. Domeij, S. U. Eisenhardt, D. Topcic, M. Albrecht, E. Leitner, K. Viitaniemi, J. B. Jowett, M. Lappas, C. Bode, I. Haviv and K. Peter (2011). "Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells." Basic Res Cardiol 106(5): 879-895.

Ahrens, I., H. Domeij, D. Topcic, I. Haviv, R. M. Merivirta, A. Agrotis, E. Leitner, J. B. Jowett, C. Bode, M. Lappas and K. Peter (2011). "Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression." PLoS One 6(8): e23210.

Ahrens, I., G. Y. Lip and K. Peter (2011). "What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?" Thromb Haemost 105(4): 574-578.

Duerschmied, D., M. Meissner, K. Peter, I. Neudorfer, F. Roming, A. Zirlik, C. Bode, D. von Elverfeldt and C. von Zur Muhlen (2011). "Molecular magnetic resonance imaging allows the detection of activated platelets in a new mouse model of coronary artery thrombosis." Invest Radiol 46(10): 618-623.

Eisenhardt, S. U., J. Habersberger, K. Oliva, G. I. Lancaster, M. Ayhan, K. J. Woollard, H. Bannasch, G. E. Rice and K. Peter (2011). "A proteomic analysis of C-reactive protein stimulated THP-1 monocytes." Proteome Sci 9(1): 1.

Fernando, H., A. M. Dart, K. Peter and J. A. Shaw (2011). "Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy." Thromb Haemost 105(6): 933-944.

Fernando, H., N. Bassler, J. Habersberger, L. J. Sheffield, R. Sharma, A. M. Dart, K. H. Peter and J. A. Shaw (2011). "Randomized double-blind placebo-controlled crossover study to determine the effects of esomeprazole on inhibition of platelet function by clopidogrel." J Thromb Haemost 9(8): 1582-1589.

Heidt, T., F. Deininger, K. Peter, J. Goldschmidt, A. Pethe, C. E. Hagemeyer, I. Neudorfer, A. Zirlik, W. A. Weber, C. Bode, P. T. Meyer, M. Behe and C. von Zur Muhlen (2011). "Activated platelets in carotid artery thrombosis in mice can be selectively targeted with a radiolabeled single-chain antibody." PLoS One 6(3): e18446.

Hu, H., P. C. Armstrong, E. Khalil, Y. C. Chen, A. Straub, M. Li, J. Soosairajah, C. E. Hagemeyer, N. Bassler, D. Huang, I. Ahrens, G. Krippner, E. Gardiner and K. Peter (2011). "GPVI and GPIbalpha mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors." PLoS One 6(4): e19190.

Kanellakis, P., A. Agrotis, T. S. Kyaw, C. Koulis, I. Ahrens, S. Mori, H. K. Takahashi, K. Liu, K. Peter, M. Nishibori and A. Bobik (2011). "High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice." Arterioscler Thromb Vasc Biol 31(2): 313-319.

Peter, K. and P. S. Myles (2011). "Perioperative antiplatelet therapy: a knife-edged choice between thrombosis and bleeding still based on consensus rather than evidence." Thromb Haemost 105(5): 750-751.

Prabhu, S., R. Sharma and K. Peter (2011). Platelets in the Pathogenesis of Vascular Disease and their Role as a Therapeutic Target. Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists. R. Fitridge and M. Thompson. Adelaide (AU), University of Adelaide Press

© The Contributors 2011.

Straub, A., S. Krajewski, J. D. Hohmann, E. Westein, F. Jia, N. Bassler, C. Selan, J. Kurz, H. P. Wendel, S. Dezfouli, Y. Yuan, H. Nandurkar, S. Jackson, M. J. Hickey and K. Peter (2011). "Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target." Arterioscler Thromb Vasc Biol 31(7): 1607-1616.

Ta, H. T., S. Prabhu, E. Leitner, F. Jia, D. von Elverfeldt, K. E. Jackson, T. Heidt, A. K. Nair, H. Pearce, C. von Zur Muhlen, X. Wang, K. Peter and C. E. Hagemeyer (2011). "Enzymatic single-chain antibody tagging: a universal approach to targeted molecular imaging and cell homing in cardiovascular disease." Circ Res 109(4): 365-373.

Topcic, D., W. Kim, J. K. Holien, F. Jia, P. C. Armstrong, J. D. Hohmann, A. Straub, G. Krippner, C. A. Haller, H. Domeij, C. E. Hagemeyer, M. W. Parker, E. L. Chaikof and K. Peter (2011). "An activation-specific platelet inhibitor that can be turned on/off by medically used hypothermia." Arterioscler Thromb Vasc Biol 31(9): 2015-2023.

Wolf, D., J. D. Hohmann, A. Wiedemann, K. Bledzka, H. Blankenbach, T. Marchini, K. Gutte, K. Zeschky, N. Bassler, N. Hoppe, A. O. Rodriguez, N. Herr, I. Hilgendorf, P. Stachon, F. Willecke, D. Duerschmied, C. von zur Muhlen, D. A. Soloviev, L. Zhang, C. Bode, E. F. Plow, P. Libby, K. Peter and A. Zirlik (2011). "Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice." Circ Res 109(11): 1269-1279.

Ahrens, I., K. Peter, G. Y. Lip and C. Bode (2012). "Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs." Discov Med 13(73): 433-443.

Ahrens, I., K. Peter, G. Y. Lip and C. Bode (2012). "Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation." Discov Med 13(73): 445-450.

Armstrong, P. C. and K. Peter (2012). "GPIIb/IIIa inhibitors: from bench to bedside and back to bench again." Thromb Haemost 107(5): 808-814.

Armstrong, P. C., H. Hu, J. Rivera, S. Rigby, Y. C. Chen, B. P. Howden, E. Gardiner and K. Peter (2012). "Staphylococcal superantigen-like protein 5 induces thrombotic and bleeding complications in vivo: inhibition by an anti-SSL5 antibody and the glycan Bimosiamose." J Thromb Haemost 10(12): 2607-2609.

Chan, W., A. E. Ajani, D. J. Clark, D. Stub, N. Andrianopoulos, A. L. Brennan, G. New, M. Sebastian, R. Johnston, A. Walton, C. M. Reid, A. M. Dart, S. J. Duffy and I. Melbourne Interventional Group (2012). "Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention." Am J Cardiol 109(4): 471-477.

Chan, W., D. Stub, D. J. Clark, A. E. Ajani, N. Andrianopoulos, A. L. Brennan, G. New, A. Black, J. A. Shaw, C. M. Reid, A. M. Dart, S. J. Duffy and I. Melbourne Interventional Group (2012). "Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention." Am J Cardiol 109(4): 478-485.

Diehl, P., A. Fricke, L. Sander, J. Stamm, N. Bassler, N. Htun, M. Ziemann, T. Helbing, A. El-Osta, J. B. Jowett and K. Peter (2012). "Microparticles: major transport vehicles for distinct microRNAs in circulation." Cardiovasc Res 93(4): 633-644.

Eisenhardt, S. U., J. Starke, J. R. Thiele, A. Murphy, G. Bjorn Stark, N. Bassler, D. Sviridov, K. Winkler and K. Peter (2012). "Pentameric CRP attenuates inflammatory effects of mmLDL by inhibiting mmLDL--monocyte interactions." Atherosclerosis 224(2): 384-393.

Habersberger, J., F. Strang, A. Scheichl, N. Htun, N. Bassler, R. M. Merivirta, P. Diehl, G. Krippner, P. Meikle, S. U. Eisenhardt, I. Meredith and K. Peter (2012). "Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction." Cardiovasc Res 96(1): 64-72.

Krajewski, S., J. Kurz, T. Geisler, K. Peter, H. P. Wendel and A. Straub (2012). "Combined blockade of ADP receptors and PI3-kinase p110beta fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation." PLoS One 7(6): e38455.

Krajewski, S., J. Kurz, B. Neumann, T. O. Greiner, A. Stolz, B. Balkau, K. Peter, K. Unertl, H. P. Wendel and A. Straub (2012). "Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia." Br J Anaesth 108(6): 912-921.

Leung, M. K., C. E. Hagemeyer, A. P. Johnston, C. Gonzales, M. M. Kamphuis, K. Ardipradja, G. K. Such, K. Peter and F. Caruso (2012). "Bio-click chemistry: enzymatic functionalization of PEGylated capsules for targeting applications." Angew Chem Int Ed Engl 51(29): 7132-7136.

Mischak, H., J. P. Ioannidis, A. Argiles, T. K. Attwood, E. Bongcam-Rudloff, M. Broenstrup, A. Charonis, G. P. Chrousos, C. Delles, A. Dominiczak, T. Dylag, J. Ehrich, J. Egido, P. Findeisen, J. Jankowski, R. W. Johnson, B. A. Julien, T. Lankisch, H. Y. Leung, D. Maahs, F. Magni, M. P. Manns, E. Manolis, G. Mayer, G. Navis, J. Novak, A. Ortiz, F. Persson, K. Peter, H. H. Riese, P. Rossing, N. Sattar, G. Spasovski, V. Thongboonkerd, R. Vanholder, J. P. Schanstra and A. Vlahou (2012). "Implementation of proteomic biomarkers: making it work." Eur J Clin Invest 42(9): 1027-1036.

Patko, Z., A. Csaszar, G. Acsady, K. Peter and M. Schwarz (2012). "Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyte-platelet aggregate formation: stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers." Platelets 23(5): 368-375.

Peter, K. and A. Bobik (2012). "HMGB1 signals danger in acute coronary syndrome: emergence of a new risk marker for cardiovascular death?" Atherosclerosis 221(2): 317-318.

Schmid, E., S. Krajewski, D. Bachmann, J. Kurz, H. P. Wendel, P. Rosenberger, B. Balkau, K. Peter, K. Unertl and A. Straub (2012). "The volatile anesthetic sevoflurane inhibits activation of neutrophil granulocytes during simulated extracorporeal circulation." Int Immunopharmacol 14(2): 202-208.

Strang, F., A. Scheichl, Y. C. Chen, X. Wang, N. M. Htun, N. Bassler, S. U. Eisenhardt, J. Habersberger and K. Peter (2012). "Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer's disease?" Brain Pathol 22(3): 337-346.

Ta, H. T., K. Peter and C. E. Hagemeyer (2012). "Enzymatic antibody tagging: toward a universal biocompatible targeting tool." Trends Cardiovasc Med 22(4): 105-111.

von Elverfeldt, D., M. Meissner, K. Peter, D. Paul, F. Meixner, I. Neudorfer, A. Merkle, A. Harloff, A. Zirlik, J. Schollhorn, M. Markl, J. Hennig, C. Bode and C. von zur Muhlen (2012). "An approach towards molecular imaging of activated platelets allows imaging of symptomatic human carotid plaques in a new model of a tissue flow chamber." Contrast Media Mol Imaging 7(2): 204-213.

von Elverfeldt, D., C. von zur Muhlen, K. Wiens, I. Neudorfer, A. Zirlik, M. Meissner, P. Tilly, A. L. Charles, C. Bode, K. Peter and J. E. Fabre (2012). "In vivo detection of activated platelets allows characterizing rupture of atherosclerotic plaques with molecular magnetic resonance imaging in mice." PLoS One 7(9): e45008.

von zur Muhlen, C., E. Schiffer, C. Sackmann, P. Zurbig, I. Neudorfer, A. Zirlik, N. Htun, A. Iphofer, L. Jansch, H. Mischak, C. Bode, Y. C. Chen and K. Peter (2012). "Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis." Mol Cell Proteomics 11(7): M111 013847.

Wang, X., C. E. Hagemeyer, J. D. Hohmann, E. Leitner, P. C. Armstrong, F. Jia, M. Olschewski, A. Needles, K. Peter and I. Ahrens (2012). "Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice." Circulation 125(25): 3117-3126.

Wolf, D., F. Jehle, A. Ortiz Rodriguez, B. Dufner, N. Hoppe, C. Colberg, A. Lozhkin, N. Bassler, B. Rupprecht, A. Wiedemann, I. Hilgendorf, P. Stachon, F. Willecke, M. Febbraio, C. von zur Muhlen, C. J. Binder, C. Bode, A. Zirlik and K. Peter (2012). "CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies." PLoS One 7(3): e33026.

Chen, Y. C., A. V. Bui, J. Diesch, R. Manasseh, C. Hausding, J. Rivera, I. Haviv, A. Agrotis, N. M. Htun, J. Jowett, C. E. Hagemeyer, R. D. Hannan, A. Bobik and K. Peter (2013). "A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling." Circ Res 113(3): 252-265.

Fink, K., H. J. Busch, N. Bourgeois, M. Schwarz, D. Wolf, A. Zirlik, K. Peter, C. Bode and C. von Zur Muhlen (2013). "Mac-1 directly binds to the endothelial protein C-receptor: a link between the protein C anticoagulant pathway and inflammation?" PLoS One 8(2): e53103.

Hohmann, J. D., X. Wang, S. Krajewski, C. Selan, C. A. Haller, A. Straub, E. L. Chaikof, H. H. Nandurkar, C. E. Hagemeyer and K. Peter (2013). "Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?" Blood 121(16): 3067-3075.

Htun, N. M. and K. Peter (2013). "Coagulation disorders and aortic stenosis: a chicken and egg question?" J Thromb Haemost 11(4): 731-732.

Peter, K. (2013). "Isoform-specific effects of protein phosphatase 1 on outside-in signalling of integrin alphaIIbbeta3: a story told by genetic manipulation of platelet surrogate cells." Thromb Haemost 109(1): 7.

Alt, K., B. M. Paterson, K. Ardipradja, C. Schieber, G. Buncic, B. Lim, S. S. Poniger, B. Jakoby, X. Wang, G. J. O'Keefe, H. J. Tochon-Danguy, A. M. Scott, U. Ackermann, K. Peter, P. S. Donnelly and C. E. Hagemeyer (2014). "Single-chain antibody conjugated to a cage amine chelator and labeled with positron-emitting copper-64 for diagnostic imaging of activated platelets." Mol Pharm 11(8): 2855-2863.

Ardipradja, K., S. D. Yeoh, K. Alt, G. O'Keefe, A. Rigopoulos, D. W. Howells, A. M. Scott, K. Peter, U. Ackerman and C. E. Hagemeyer (2014). "Detection of activated platelets in a mouse model of carotid artery thrombosis with 18 F-labeled single-chain antibodies." Nucl Med Biol 41(3): 229-237.

Braig, D., B. Kaiser, J. R. Thiele, H. Bannasch, K. Peter, G. B. Stark, H. G. Koch and S. U. Eisenhardt (2014). "A conformational change of C-reactive protein in burn wounds unmasks its proinflammatory properties." Int Immunol 26(8): 467-478.

Brennan, A. L., N. Andrianopoulos, S. J. Duffy, C. M. Reid, D. J. Clark, P. Loane, G. New, A. Black, B. P. Yan, M. Brooks, L. Roberts, E. A. Carroll, J. Lefkovits, A. E. Ajani and I. Melbourne Interventional Group (2014). "Trends in door-to-balloon time and outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an Australian perspective." Intern Med J 44(5): 471-477.

Guo, J., Y. Ping, H. Ejima, K. Alt, M. Meissner, J. J. Richardson, Y. Yan, K. Peter, D. von Elverfeldt, C. E. Hagemeyer and F. Caruso (2014). "Engineering multifunctional capsules through the assembly of metal-phenolic networks." Angew Chem Int Ed Engl 53(22): 5546-5551.

Htun, N. M. and K. Peter (2014). "Biomarkers for AAA: Encouraging steps but clinical relevance still to be delivered." Proteomics Clin Appl 8(9-10): 732-734.

Koulis, C., Y. C. Chen, C. Hausding, I. Ahrens, T. S. Kyaw, C. Tay, T. Allen, K. Jandeleit-Dahm, M. J. Sweet, S. Akira, A. Bobik, K. Peter and A. Agrotis (2014). "Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice." Arterioscler Thromb Vasc Biol 34(3): 516-525.

Liu, J., K. Peter, D. Shi, L. Zhang, G. Dong, D. Zhang, H. Breiteneder, R. Bauer, J. Jakowitsch and Y. Ma (2014). "Anti-inflammatory effects of the chinese herbal formula sini tang in myocardial infarction rats." Evid Based Complement Alternat Med 2014: 309378.

Paterson, B. M., K. Alt, C. M. Jeffery, R. I. Price, S. Jagdale, S. Rigby, C. C. Williams, K. Peter, C. E. Hagemeyer and P. S. Donnelly (2014). "Enzyme-mediated site-specific bioconjugation of metal complexes to proteins: sortase-mediated coupling of copper-64 to a single-chain antibody." Angew Chem Int Ed Engl 53(24): 6115-6119.

Sugumar, H., T. F. Lancefield, N. Andrianopoulos, S. J. Duffy, A. E. Ajani, M. Freeman, B. Buxton, A. L. Brennan, B. P. Yan, D. T. Dinh, J. A. Smith, K. Charter, O. Farouque, C. M. Reid, D. J. Clark, Australia, C. New Zealand Society of, S. Thoracic and G. Melbourne Interventional (2014). "Impact of renal function in patients with multi-vessel coronary disease on long-term mortality following coronary artery bypass grafting compared with percutaneous coronary intervention." Int J Cardiol 172(2): 442-449.

Thiele, J. R., J. Habersberger, D. Braig, Y. Schmidt, K. Goerendt, V. Maurer, H. Bannasch, A. Scheichl, K. J. Woollard, E. von Dobschutz, F. Kolodgie, R. Virmani, G. B. Stark, K. Peter and S. U. Eisenhardt (2014). "Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy." Circulation 130(1): 35-50.

von Elverfeldt, D., A. Maier, D. Duerschmied, M. Braig, T. Witsch, X. Wang, M. Mauler, I. Neudorfer, M. Menza, M. Idzko, A. Zirlik, T. Heidt, P. Bronsert, C. Bode, K. Peter and C. von Zur Muhlen (2014). "Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging." Circulation 130(8): 676-687.

Wang, X., J. Palasubramaniam, Y. Gkanatsas, J. D. Hohmann, E. Westein, R. Kanojia, K. Alt, D. Huang, F. Jia, I. Ahrens, R. L. Medcalf, K. Peter and C. E. Hagemeyer (2014). "Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets." Circ Res 114(7): 1083-1093.

Willecke, F., S. Tiwari, B. Rupprecht, D. Wolf, S. Hergeth, N. Hoppe, B. Dufner, L. Schulte, N. Anto Michel, N. Bukosza, T. Marchini, M. Jackel, P. Stachon, I. Hilgendorf, K. Zeschky, R. Schleicher, H. F. Langer, C. von Zur Muhlen, C. Bode, K. Peter and A. Zirlik (2014). "Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice." Thromb Haemost 112(2): 379-389.

Wolf, D., F. Jehle, N. A. Michel, E. N. Bukosza, J. Rivera, Y. C. Chen, N. Hoppe, B. Dufner, A. O. Rodriguez, C. Colberg, L. Nieto, B. Rupprecht, A. Wiedemann, L. Schulte, A. Peikert, N. Bassler, A. Lozhkin, S. P. Hergeth, P. Stachon, I. Hilgendorf, F. Willecke, C. von Zur Muhlen, D. von Elverfeldt, C. J. Binder, P. Aichele, N. Varo, M. A. Febbraio, P. Libby, C. Bode, K. Peter and A. Zirlik (2014). "Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice." Circulation 129(23): 2414-2425.

Abraham, M. K., A. Nolte, R. Reus, A. Behring, D. Zengerle, M. Avci-Adali, J. D. Hohmann, K. Peter, C. Schlensak, H. P. Wendel and S. Krajewski (2015). "In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications." PLoS One 10(9): e0138375.

Ahrens, I., Y. C. Chen, D. Topcic, M. Bode, D. Haenel, C. E. Hagemeyer, H. Seeba, D. Duerschmied, N. Bassler, K. A. Jandeleit-Dahm, M. J. Sweet, A. Agrotis, A. Bobik and K. Peter (2015). "HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi." Thromb Haemost 114(5): 994-1003.

Alt, K., B. M. Paterson, E. Westein, S. E. Rudd, S. S. Poniger, S. Jagdale, K. Ardipradja, T. U. Connell, G. Y. Krippner, A. K. Nair, X. Wang, H. J. Tochon-Danguy, P. S. Donnelly, K. Peter and C. E. Hagemeyer (2015). "A versatile approach for the site-specific modification of recombinant antibodies using a combination of enzyme-mediated bioconjugation and click chemistry." Angew Chem Int Ed Engl 54(26): 7515-7519.

Chan, C. T., C. G. Sobey, M. Lieu, D. Ferens, M. M. Kett, H. Diep, H. A. Kim, S. M. Krishnan, C. V. Lewis, E. Salimova, P. Tipping, A. Vinh, C. S. Samuel, K. Peter, T. J. Guzik, T. S. Kyaw, B. H. Toh, A. Bobik and G. R. Drummond (2015). "Obligatory Role for B Cells in the Development of Angiotensin II-Dependent Hypertension." Hypertension 66(5): 1023-1033.

Chen, Y. C. and K. Peter (2015). "Determining the characteristics of human atherosclerosis: A difficult but indispensable task providing the direction and proof of concept for pioneering atherosclerosis research in animal models." Atherosclerosis 241(2): 595-596.

Chen, Y. C., J. Rivera and K. Peter (2015). "Tandem Stenosis to Induce Atherosclerotic Plaque Instability in the Mouse." Methods Mol Biol 1339: 333-338.

Cui, J., R. De Rose, K. Alt, S. Alcantara, B. M. Paterson, K. Liang, M. Hu, J. J. Richardson, Y. Yan, C. M. Jeffery, R. I. Price, K. Peter, C. E. Hagemeyer, P. S. Donnelly, S. J. Kent and F. Caruso (2015). "Engineering poly(ethylene glycol) particles for improved biodistribution." ACS Nano 9(2): 1571-1580.

Flierl, U., T. L. Nero, B. Lim, J. F. Arthur, Y. Yao, S. M. Jung, E. Gitz, A. Y. Pollitt, M. T. Zaldivia, M. Jandrot-Perrus, A. Schafer, B. Nieswandt, R. K. Andrews, M. W. Parker, E. E. Gardiner and K. Peter (2015). "Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators." J Exp Med 212(2): 129-137.

Gunawan, S. T., K. Kempe, T. Bonnard, J. Cui, K. Alt, L. S. Law, X. Wang, E. Westein, G. K. Such, K. Peter, C. E. Hagemeyer and F. Caruso (2015). "Multifunctional Thrombin-Activatable Polymer Capsules for Specific Targeting to Activated Platelets." Adv Mater 27(35): 5153-5157.

Guo, J., X. Wang, D. C. Henstridge, J. J. Richardson, J. Cui, A. Sharma, M. A. Febbraio, K. Peter, J. B. de Haan, C. E. Hagemeyer and F. Caruso (2015). "Nanoporous Metal-Phenolic Particles as Ultrasound Imaging Probes for Hydrogen Peroxide." Adv Healthc Mater 4(14): 2170-2175.

Hagemeyer, C. E., K. Alt, A. P. Johnston, G. K. Such, H. T. Ta, M. K. Leung, S. Prabhu, X. Wang, F. Caruso and K. Peter (2015). "Particle generation, functionalization and sortase A-mediated modification with targeting of single-chain antibodies for diagnostic and therapeutic use." Nat Protoc 10(1): 90-105.

Kim, W., C. Haller, E. Dai, X. Wang, C. E. Hagemeyer, D. R. Liu, K. Peter and E. L. Chaikof (2015). "Targeted antithrombotic protein micelles." Angew Chem Int Ed Engl 54(5): 1461-1465.

McLellan, A. J., M. P. Schlaich, A. J. Taylor, S. Prabhu, D. Hering, L. Hammond, P. Marusic, J. Duval, Y. Sata, A. Ellims, M. Esler, K. Peter, J. Shaw, A. Walton, J. M. Kalman and P. M. Kistler (2015). "Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering." Heart Rhythm 12(5): 982-990.

Meier, S., G. Putz, U. Massing, C. E. Hagemeyer, D. von Elverfeldt, M. Meissner, K. Ardipradja, S. Barnert, K. Peter, C. Bode, R. Schubert and C. von zur Muhlen (2015). "Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis." Biomaterials 53: 137-148.

NM, H. and P. K (2015). "Non-vitamin K antagonist oral anticoagulants (NOACs) in the cardiac catherisation laboratory: friends or foes?" Thrombosis and Haemostasis 114(2): 214-216.

Thiele, J. R., J. Zeller, H. Bannasch, G. B. Stark, K. Peter and S. U. Eisenhardt (2015). "Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes." Mediators Inflamm 2015: 372432.

Bei, J. J., C. Liu, S. Peng, C. H. Liu, W. B. Zhao, X. L. Qu, Q. Chen, Z. Zhou, Z. P. Yu, K. Peter and H. Y. Hu (2016). "Staphylococcal SSL5-induced platelet microparticles provoke proinflammatory responses via the CD40/TRAF6/NFkappaB signalling pathway in monocytes." Thromb Haemost 115(3): 632-645.

Cabrera-Fuentes, H. A., J. Aragones, J. Bernhagen, A. Boening, W. A. Boisvert, H. E. Botker, H. Bulluck, S. Cook, F. Di Lisa, F. B. Engel, B. Engelmann, F. Ferrazzi, P. Ferdinandy, A. Fong, I. Fleming, E. Gnaiger, S. Hernandez-Resendiz, S. B. Kalkhoran, M. H. Kim, S. Lecour, E. A. Liehn, M. S. Marber, M. Mayr, T. Miura, S. B. Ong, K. Peter, D. Sedding, M. K. Singh, M. S. Suleiman, H. J. Schnittler, R. Schulz, W. Shim, D. Tello, C. W. Vogel, M. Walker, Q. O. Li, D. M. Yellon, D. J. Hausenloy and K. T. Preissner (2016). "From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research"." Basic Res Cardiol 111(6): 69.

Chen, Y. C., A. L. Huang, T. S. Kyaw, A. Bobik and K. Peter (2016). "Atherosclerotic Plaque Rupture: Identifying the Straw That Breaks the Camel's Back." Arterioscler Thromb Vasc Biol 36(8): e63-72.

Chen, Y. C., J. Rivera, M. Fitzgerald, C. Hausding, Y. L. Ying, X. Wang, K. Todorova, S. Hayrabedyan, E. R. Barnea and K. Peter (2016). "PreImplantation factor prevents atherosclerosis via its immunomodulatory effects without affecting serum lipids." Thromb Haemost 115(5): 1010-1024.

Heidt, T., S. Ehrismann, J. B. Hovener, I. Neudorfer, I. Hilgendorf, M. Reisert, C. E. Hagemeyer, A. Zirlik, J. Reinohl, C. Bode, K. Peter, D. von Elverfeldt and C. von Zur Muhlen (2016). "Molecular Imaging of Activated Platelets Allows the Detection of Pulmonary Embolism with Magnetic Resonance Imaging." Sci Rep 6: 25044.

Hering, D., P. Marusic, A. S. Walton, J. Duval, R. Lee, Y. Sata, H. Krum, E. Lambert, K. Peter, G. Head, G. Lambert, M. D. Esler and M. P. Schlaich (2016). "Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension." Int J Cardiol 202: 388-393.

McFadyen, J. and K. Peter (2016). "Forget about thrombosis: Platelets and Alzheimer's disease, yet another sticky situation." Sci Signal 9(429): fs9.

Tay, C., Y. H. Liu, H. Hosseini, P. Kanellakis, A. Cao, K. Peter, P. Tipping, A. Bobik, B. H. Toh and T. Kyaw (2016). "B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation." Cardiovasc Res 111(4): 385-397.

von Zur Muhlen, C., T. Koeck, E. Schiffer, C. Sackmann, P. Zurbig, I. Hilgendorf, J. Reinohl, J. Rivera, A. Zirlik, C. Hehrlein, H. Mischak, C. Bode and K. Peter (2016). "Urine proteome analysis as a discovery tool in patients with deep vein thrombosis and pulmonary embolism." Proteomics Clin Appl 10(5): 574-584.

Wang, X., Y. Gkanatsas, J. Palasubramaniam, J. D. Hohmann, Y. C. Chen, B. Lim, C. E. Hagemeyer and K. Peter (2016). "Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis." Theranostics 6(5): 726-738.

Weber, C., E. Shantsila, M. Hristov, G. Caligiuri, T. Guzik, G. H. Heine, I. E. Hoefer, C. Monaco, K. Peter, E. Rainger, A. Siegbahn, S. Steffens, J. Wojta and G. Y. Lip (2016). "Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis"." Thromb Haemost 116(4): 626-637.

Ziegler, M., K. Alt, B. M. Paterson, P. Kanellakis, A. Bobik, P. S. Donnelly, C. E. Hagemeyer and K. Peter (2016). "Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated Platelets." Sci Rep 6(1): 38161.

Abraham, M. K., K. Peter, T. Michel, H. P. Wendel, S. Krajewski and X. Wang (2017). "Nanoliposomes for Safe and Efficient Therapeutic mRNA Delivery: A Step Toward Nanotheranostics in Inflammatory and Cardiovascular Diseases as well as Cancer." Nanotheranostics 1(2): 154-165.

Baratchi, S., K. Khoshmanesh, O. L. Woodman, S. Potocnik, K. Peter and P. McIntyre (2017). "Molecular Sensors of Blood Flow in Endothelial Cells." Trends Mol Med 23(9): 850-868.

Bonnard, T., Z. Tennant, B. Niego, R. Kanojia, K. Alt, S. Jagdale, L. S. Law, S. Rigby, R. L. Medcalf, K. Peter and C. E. Hagemeyer (2017). "Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa." J Am Heart Assoc 6(2).

Braig, D., T. L. Nero, H. G. Koch, B. Kaiser, X. Wang, J. R. Thiele, C. J. Morton, J. Zeller, J. Kiefer, L. A. Potempa, N. A. Mellett, L. A. Miles, X. J. Du, P. J. Meikle, M. Huber-Lang, G. B. Stark, M. W. Parker, K. Peter and S. U. Eisenhardt (2017). "Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites." Nat Commun 8: 14188.

Gunther, F., T. Heidt, M. Kramer, E. Khanicheh, A. L. Klibanov, A. Geibel-Zehender, E. A. Ferrante, I. Hilgendorf, D. Wolf, A. Zirlik, J. Reinohl, C. Bode, K. Peter, B. A. Kaufmann and C. V. Z. Muhlen (2017). "Dual targeting improves capture of ultrasound microbubbles towards activated platelets but yields no additional benefit for imaging of arterial thrombosis." Sci Rep 7(1): 14898.

Hortmann, M., S. Robinson, M. Mohr, D. Haenel, M. Mauler, R. Laumann, D. Stallmann, J. Reinoehl, D. Duerschmied, K. Peter, C. Bode and I. Ahrens (2017). "Circulating HtrA2 after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A potential novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury." Int J Cardiol 249: 437.

Htun, N. M., Y. C. Chen, B. Lim, T. Schiller, G. J. Maghzal, A. L. Huang, K. D. Elgass, J. Rivera, H. G. Schneider, B. R. Wood, R. Stocker and K. Peter (2017). "Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques." Nat Commun 8(1): 75.

Htun, N. M., D. J. Magliano, Z. Y. Zhang, J. Lyons, T. Petit, E. Nkuipou-Kenfack, A. Ramirez-Torres, C. von Zur Muhlen, D. Maahs, J. P. Schanstra, C. Pontillo, M. Pejchinovski, J. K. Snell-Bergeon, C. Delles, H. Mischak, J. A. Staessen, J. E. Shaw, T. Koeck and K. Peter (2017). "Prediction of acute coronary syndromes by urinary proteome analysis." PLoS One 12(3): e0172036.

Huang, A. L., J. J. Bosco and K. Peter (2017). "Mast Cell: An Unexpected Villain in Venous Thromboembolism?" Circ Res 121(8): 899-901.

Jamasbi, J., K. Ayabe, S. Goto, B. Nieswandt, K. Peter and W. Siess (2017). "Platelet receptors as therapeutic targets: Past, present and future." Thromb Haemost 117(7): 1249-1257.

Kyaw, T., K. Peter, Y. Li, P. Tipping, B. H. Toh and A. Bobik (2017). "Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges." Br J Pharmacol 174(22): 3956-3972.

Lim, B., Y. Yao, A. L. Huang, M. L. Yap, U. Flierl, J. Palasubramaniam, M. T. K. Zaldivia, X. Wang and K. Peter (2017). "A Unique Recombinant Fluoroprobe Targeting Activated Platelets Allows In Vivo Detection of Arterial Thrombosis and Pulmonary Embolism Using a Novel Three-Dimensional Fluorescence Emission Computed Tomography (FLECT) Technology." Theranostics 7(5): 1047-1061.

Maier, A., P. Plaza-Heck, F. Meixner, F. Guenther, B. A. Kaufmann, M. Kramer, T. Heidt, A. Zirlik, I. Hilgendorf, J. Reinohl, P. Stachon, P. Bronsert, R. Birkemeyer, I. Neudorfer, K. Peter, C. Bode and C. von Zur Muhlen (2017). "A molecular intravascular ultrasound contrast agent allows detection of activated platelets on the surface of symptomatic human plaques." Atherosclerosis 267: 68-77.

McFadyen, J. D. and K. Peter (2017). "Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding." Circ Res 121(10): 1133-1135.

McFadyen, J. D., P. J. Meikle and K. Peter (2017). "Platelet lipidomics: a window of opportunity to assess cardiovascular risk?" Eur Heart J 38(25): 2006-2008.

Michel, T., D. Luft, M. K. Abraham, S. Reinhardt, M. L. Salinas Medina, J. Kurz, M. Schaller, M. Avci-Adali, C. Schlensak, K. Peter, H. P. Wendel, X. Wang and S. Krajewski (2017). "Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications." Mol Ther Nucleic Acids 8: 459-468.

Pietersz, G. A., X. Wang, M. L. Yap, B. Lim and K. Peter (2017). "Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies." Nanomedicine (Lond) 12(15): 1873-1889.

Sashindranath, M., K. M. Dwyer, S. Dezfouli, C. Selan, S. Crikis, B. Lu, Y. Yuan, M. J. Hickey, K. Peter, S. C. Robson, P. J. Cowan and H. H. Nandurkar (2017). "Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury." Purinergic Signal 13(2): 259-265.

Ta, H. T., Z. Li, C. E. Hagemeyer, G. Cowin, S. Zhang, J. Palasubramaniam, K. Alt, X. Wang, K. Peter and A. K. Whittaker (2017). "Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast." Biomaterials 134: 31-42.

Wang, X. and K. Peter (2017). "Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing." Arterioscler Thromb Vasc Biol 37(6): 1029-1040.

Wolf, D., N. Bukosza, D. Engel, M. Poggi, F. Jehle, N. Anto Michel, Y. C. Chen, C. Colberg, N. Hoppe, B. Dufner, L. Boon, H. Blankenbach, I. Hilgendorf, C. von Zur Muhlen, J. Reinohl, B. Sommer, T. Marchini, M. A. Febbraio, C. Weber, C. Bode, K. Peter, E. Lutgens and A. Zirlik (2017). "Inflammation, but not recruitment, of adipose tissue macrophages requires signalling through Mac-1 (CD11b/CD18) in diet-induced obesity (DIO)." Thromb Haemost 117(2): 325-338.

Yap, M. L., J. D. McFadyen, X. Wang, N. A. Zia, J. D. Hohmann, M. Ziegler, Y. Yao, A. Pham, M. Harris, P. S. Donnelly, P. M. Hogarth, G. A. Pietersz, B. Lim and K. Peter (2017). "Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging." Theranostics 7(10): 2565-2574.

Ying, Y. L., Y. C. Chen, K. Jandeleit-Dahm and K. Peter (2017). "GLP-1 receptor agonists: An example of the challenge for animal models to predict plaque instability/rupture and cardiovascular outcomes." Atherosclerosis 265: 250-252.

Zaldivia, M. T. K., J. D. McFadyen, B. Lim, X. Wang and K. Peter (2017). "Platelet-Derived Microvesicles in Cardiovascular Diseases." Front Cardiovasc Med 4: 74.

Zaldivia, M. T., J. Rivera, D. Hering, P. Marusic, Y. Sata, B. Lim, N. Eikelis, R. Lee, G. W. Lambert, M. D. Esler, N. M. Htun, J. Duval, L. Hammond, S. U. Eisenhardt, U. Flierl, M. P. Schlaich and K. Peter (2017). "Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk." Hypertension 69(2): 323-331.

Ziegler, M., X. Wang, B. Lim, E. Leitner, F. Klingberg, V. Ching, Y. Yao, D. Huang, X. M. Gao, H. Kiriazis, X. J. Du, J. J. Haigh, A. Bobik, C. E. Hagemeyer, I. Ahrens and K. Peter (2017). "Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury." Theranostics 7(13): 3192-3206.

Diehl, P., D. S. Gaul, J. Sogl, U. Flierl, D. Henstridge, J. Pahla, H. Bugger, M. Y. Emmert, F. Ruschitzka, C. Bode, T. F. Lüscher, M. Moser, C. M. Matter, K. Peter and S. Winnik (2018). "The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts." J Thromb Thrombolysis 46(1): 102-112.

Flierl, U., T. L. Nero, B. Lim, R. K. Andrews, M. W. Parker, E. E. Gardiner and K. Peter (2018). "Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment." J Thromb Haemost 16(1): 181-185.

Guzik, T. J., C. Antoniades, A. H. Baker, D. G. Harrison, C. M. Loughrey, P. Maffia, E. Murphy, S. A. Nicklin, K. Peter, J. Pearson and B. Casadei (2018). "What matters in Cardiovascular Research? Scientific discovery driving clinical delivery." Cardiovasc Res 114(12): 1565-1568.

Hanjaya-Putra, D., C. Haller, X. Wang, E. Dai, B. Lim, L. Liu, P. Jaminet, J. Yao, A. Searle, T. Bonnard, C. E. Hagemeyer, K. Peter and E. L. Chaikof (2018). "Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis." JCI Insight 3(15).

Hosseini, H., L. Yi, P. Kanellakis, A. Cao, C. Tay, K. Peter, A. Bobik, B. H. Toh and T. Kyaw (2018). "Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells." J Am Heart Assoc 7(13).

McFadyen, J. D., M. Schaff and K. Peter (2018). "Current and future antiplatelet therapies: emphasis on preserving haemostasis." Nat Rev Cardiol 15(3): 181-191.

McFadyen, J. D., J. Kiefer, D. Braig, J. Loseff-Silver, L. A. Potempa, S. U. Eisenhardt and K. Peter (2018). "Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes." Front Immunol 9: 1351.

McFadyen, J. D. and K. Peter (2018). "Platelet lipidomics and function: joining the dots." Blood 132(5): 465-466.

Rashid, I., G. J. Maghzal, Y. C. Chen, D. Cheng, J. Talib, D. Newington, M. Ren, S. K. Vajandar, A. Searle, A. Maluenda, E. L. Lindstedt, A. Jabbour, A. J. Kettle, A. Bongers, C. Power, E. Michaëlsson, K. Peter and R. Stocker (2018). "Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque." Eur Heart J 39(35): 3301-3310.

Robinson, S., M. Follo, D. Haenel, M. Mauler, D. Stallmann, L. A. Heger, T. Helbing, D. Duerschmied, K. Peter, C. Bode, I. Ahrens and M. Hortmann (2018). "Chip-based digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction patients." Acta Pharmacol Sin 39(7): 1217-1227.

Robinson, S., M. Follo, D. Haenel, M. Mauler, D. Stallmann, M. Tewari, D. Duerschmied, K. Peter, C. Bode, I. Ahrens and M. Hortmann (2018). "Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction." Int J Cardiol 257: 247-254.

Samudra, A. N., K. M. Dwyer, C. Selan, S. Freddi, L. Murray-Segal, M. Nikpour, M. J. Hickey, K. Peter, S. C. Robson, M. Sashindranath, P. J. Cowan and H. H. Nandurkar (2018). "CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages." J Autoimmun 88: 131-138.

Sata, Y., D. Hering, G. A. Head, A. S. Walton, K. Peter, P. Marusic, J. Duval, R. Lee, L. J. Hammond, E. A. Lambert, G. W. Lambert, M. D. Esler and M. P. Schlaich (2018). "Ambulatory arterial stiffness index as a predictor of blood pressure response to renal denervation." J Hypertens 36(6): 1414-1422.

Sonia D'Souza, C., Z. Li, D. Luke Maxwell, O. Trusler, M. Murphy, S. Crewther, K. Peter and J. M. Orian (2018). "Platelets Drive Inflammation and Target Gray Matter and the Retina in Autoimmune-Mediated Encephalomyelitis." J Neuropathol Exp Neurol 77(7): 567-576.

Ta, H. T., N. P. Truong, A. K. Whittaker, T. P. Davis and K. Peter (2018). "The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases." Expert Opin Drug Deliv 15(1): 33-45.

Thiele, J. R., J. Zeller, J. Kiefer, D. Braig, S. Kreuzaler, Y. Lenz, L. A. Potempa, F. Grahammer, T. B. Huber, M. Huber-Lang, H. Bannasch, G. B. Stark, K. Peter and S. U. Eisenhardt (2018). "A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury." Front Immunol 9: 675.

Wang, X., A. K. Searle, J. D. Hohmann, A. L. Liu, M. K. Abraham, J. Palasubramaniam, B. Lim, Y. Yao, M. Wallert, E. Yu, Y. C. Chen and K. Peter (2018). "Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development." Mol Ther 26(4): 1056-1065.

Wolf, D., N. Anto-Michel, H. Blankenbach, A. Wiedemann, K. Buscher, J. D. Hohmann, B. Lim, M. Bäuml, A. Marki, M. Mauler, D. Duerschmied, Z. Fan, H. Winkels, D. Sidler, P. Diehl, D. M. Zajonc, I. Hilgendorf, P. Stachon, T. Marchini, F. Willecke, M. Schell, B. Sommer, C. von Zur Muhlen, J. Reinöhl, T. Gerhardt, E. F. Plow, V. Yakubenko, P. Libby, C. Bode, K. Ley, K. Peter and A. Zirlik (2018). "A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense." Nat Commun 9(1): 525.

Yap, M. L., X. Wang, G. A. Pietersz and K. Peter (2018). "Mesoscale Nanoparticles: An Unexpected Means for Selective Therapeutic Targeting of Kidney Diseases!" Hypertension 71(1): 61-63.

Ziegler, M., J. D. Hohmann, A. K. Searle, M. K. Abraham, H. H. Nandurkar, X. Wang and K. Peter (2018). "A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury." Eur Heart J 39(2): 111-116.

Antonipillai, J., S. Rigby, N. Bassler, K. Peter and O. Bernard (2019). "Pharmacological inhibition of LIM kinase pathway impairs platelets functionality and facilitates thrombolysis." Exp Cell Res 382(2): 111458.

Bienvenu, L. A., X. Wang and K. Peter (2019). "Prime time viewing of the ischaemic heart: new technologies allow imaging and flow assessment of the microvasculature in the beating heart." Cardiovasc Res 115(13): 1817-1819.

Carnagarin, R., V. Matthews, M. T. K. Zaldivia, K. Peter and M. P. Schlaich (2019). "The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension." Br J Pharmacol 176(12): 1839-1852.

Diehl, P., F. Nienaber, M. T. K. Zaldivia, J. Stamm, P. M. Siegel, N. A. Mellett, M. Wessinger, X. Wang, J. D. McFadyen, N. Bassler, G. Puetz, N. M. Htun, D. Braig, J. Habersberger, T. Helbing, S. U. Eisenhardt, M. Fuller, C. Bode, P. J. Meikle, Y. C. Chen and K. Peter (2019). "Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability." Thromb Haemost 119(8): 1295-1310.

Granja, T., A. Körner, C. Glück, J. D. Hohmann, X. Wang, D. Köhler, A. Streißenberger, H. H. Nandurkar, V. Mirakaj, P. Rosenberger, K. Peter and A. Straub (2019). "Targeting CD39 Toward Activated Platelets Reduces Systemic Inflammation and Improves Survival in Sepsis: A Preclinical Pilot Study." Crit Care Med 47(5): e420-e427.

Heger, L. A., M. Hortmann, M. Albrecht, C. Colberg, K. Peter, T. Witsch, D. Stallmann, A. Zirlik, C. Bode, D. Duerschmied and I. Ahrens (2019). "Inflammation in acute coronary syndrome: Expression of TLR2 mRNA is increased in platelets of patients with ACS." PLoS One 14(10): e0224181.

Hortmann, M., S. Robinson, M. Mohr, M. Mauler, D. Stallmann, J. Reinohl, D. Duerschmied, K. Peter, J. Carr, C. M. Gibson, C. Bode and I. Ahrens (2019). "The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction." Eur Heart J Acute Cardiovasc Care 8(8): 695-702.

Kaur, G., D. Stallmann, N. Schanze, R. Laumann, L. A. Heger, J. Steinfurt, P. Stachon, K. Peter, C. Bode, M. Moser, I. Ahrens, D. Duerschmied and M. Hortmann (2019). "Extracellular HtrA2 Induces Apoptosis in Human Umbilical Vein Endothelial Cells." Int J Mol Sci 20(21).

Kocovski, P., X. Jiang, C. S. D'Souza, Z. Li, P. T. Dang, X. Wang, W. Chen, K. Peter, M. W. Hale and J. M. Orian (2019). "Platelet Depletion is Effective in Ameliorating Anxiety-Like Behavior and Reducing the Pro-Inflammatory Environment in the Hippocampus in Murine Experimental Autoimmune Encephalomyelitis." J Clin Med 8(2).

Koh, J. Q. S., H. Fernando, K. Peter and D. Stub (2019). "Opioids and ST Elevation Myocardial Infarction: A Systematic Review." Heart Lung Circ 28(5): 697-706.

Krishnan, S. M., Y. H. Ling, B. M. Huuskes, D. M. Ferens, N. Saini, C. T. Chan, H. Diep, M. M. Kett, C. S. Samuel, B. K. Kemp-Harper, A. A. B. Robertson, M. A. Cooper, K. Peter, E. Latz, A. S. Mansell, C. G. Sobey, G. R. Drummond and A. Vinh (2019). "Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension." Cardiovasc Res 115(4): 776-787.

McFadyen, J. D., H. Fernando and K. Peter (2019). "Off-target drug effects on platelet function: Protecting an Achilles heel of drug development." Current Opinion in Toxicology 17: 9-17.

Michel, T., A. Link, M. K. Abraham, C. Schlensak, K. Peter, H. P. Wendel, X. Wang and S. Krajewski (2019). "Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA." J Vis Exp(144).

Mohammed, M., P. Thurgood, C. Gilliam, N. Nguyen, E. Pirogova, K. Peter, K. Khoshmanesh and S. Baratchi (2019). "Studying the Response of Aortic Endothelial Cells under Pulsatile Flow Using a Compact Microfluidic System." Anal Chem 91(18): 12077-12084.

Palasubramaniam, J., X. Wang and K. Peter (2019). "Myocardial Infarction-From Atherosclerosis to Thrombosis." Arterioscler Thromb Vasc Biol 39(8): e176-e185.

Pearce, H. A., H. Qian, T. U. Connell, D. Huang, C. Gottstein, P. S. Donnelly, K. Peter, P. Gregorevic and C. E. Hagemeyer (2019). "Site-Specific Glycation and Chemo-enzymatic Antibody Sortagging for the Retargeting of rAAV6 to Inflamed Endothelium." Mol Ther Methods Clin Dev 14: 261-269.

Ranasinghe, M. P., K. Peter and J. D. McFadyen (2019). "Thromboembolic and Bleeding Complications in Transcatheter Aortic Valve Implantation: Insights on Mechanisms, Prophylaxis and Therapy." J Clin Med 8(2).

Wallert, M., J. Bauer, S. Kluge, L. Schmolz, Y. C. Chen, M. Ziegler, A. K. Searle, A. Maxones, M. Schubert, M. Thurmer, H. Pein, A. Koeberle, O. Werz, M. Birringer, K. Peter and S. Lorkowski (2019). "The vitamin E derivative garcinoic acid from Garcinia kola nut seeds attenuates the inflammatory response." Redox Biol 24: 101166.

Wang, X. and K. Peter (2019). "Mending the failing heart." Aging (Albany NY) 11(6): 1605-1606.

Ward, C. M., R. K. Andrews and I. S. o. t. A. Speakers (2019). "Illustrated State-of-the-Art Capsules of the ISTH 2019 Congress in Melbourne, Australia." Res Pract Thromb Haemost 3(3): 431-497.

Yap, M. L., J. D. McFadyen, X. Wang, M. Ziegler, Y. C. Chen, A. Willcox, C. J. Nowell, A. M. Scott, E. K. Sloan, P. M. Hogarth, G. A. Pietersz and K. Peter (2019). "Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases." Theranostics 9(4): 1154-1169.

Yap, M. L. and K. Peter (2019). "Molecular Positron Emission Tomography in Cardiac Ischemia/Reperfusion." Circ Res 124(6): 827-829.

Ziegler, M., X. Wang and K. Peter (2019). "Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target." Cardiovasc Res 115(7): 1178-1188.

Ziegler, M., K. Haigh, T. Nguyen, X. Wang, B. Lim, M. L. Yap, E. M. Eddy, J. J. Haigh and K. Peter (2019). "The pulmonary microvasculature entraps induced vascular progenitor cells (iVPCs) systemically delivered after cardiac ischemia-reperfusion injury: Indication for preservation of heart function via paracrine effects beyond engraftment." Microcirculation 26(2): e12493.

Ziegler, M., X. Xu, M. L. Yap, H. Hu, J. Zhang and K. Peter (2019). "A Self-Assembled Fluorescent Nanoprobe for Imaging and Therapy of Cardiac Ischemia/Reperfusion Injury." Advanced Therapeutics 2(3): 1800133.

Baratchi, S., Y. C. Chen and K. Peter (2020). "Helical flow: A means to identify unstable plaques and a new direction for the design of vascular grafts and stents." Atherosclerosis 300: 34-36.

Baratchi, S., M. T. K. Zaldivia, M. Wallert, J. Loseff-Silver, S. Al-Aryahi, J. Zamani, P. Thurgood, A. Salim, N. M. Htun, D. Stub, P. Vahidi, S. J. Duffy, A. Walton, T. H. Nguyen, A. Jaworowski, K. Khoshmanesh and K. Peter (2020). "Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress-Induced, Piezo-1-Mediated Monocyte Activation." Circulation 142(11): 1092-1105.

Bienvenu, L. A., A. Maluenda, J. D. McFadyen, A. K. Searle, E. Yu, C. Haller, E. L. Chaikof, K. Peter and X. Wang (2020). "Combined Antiplatelet/Anticoagulant Drug for Cardiac Ischemia/Reperfusion Injury." Circ Res 127(9): 1211-1213.

Bienvenu, L. A., J. Noonan, X. Wang and K. Peter (2020). "Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities." Cardiovasc Res 116(14): 2197-2206.

Fernando, H., J. D. McFadyen, J. Palasubramaniam, J. Shaw, X. Wang, D. Stub and K. Peter (2020). "Antithrombotic Therapy in Myocardial Infarction: Historic Perils and Current Challenges-A 70-Year Journey." Thromb Haemost 120(10): 1352-1356.

Fernando, H., Z. Nehme, K. Peter, S. Bernard, M. Stephenson, J. Bray, P. Cameron, A. Ellims, A. Taylor, D. M. Kaye, K. Smith, D. Stub and A. investigators (2020). "Prehospital opioid dose and myocardial injury in patients with ST elevation myocardial infarction." Open Heart 7(2): e001307.

Maier, A., M. Braig, K. Jakob, T. Bienert, M. Schaper, A. Merkle, C. Wadle, M. Menza, I. Neudorfer, I. Bojti, P. Stachon, D. Duerschmied, I. Hilgendorf, T. Heidt, C. Bode, K. Peter, K. Klingel, D. von Elverfeldt and C. von Zur Muhlen (2020). "Molecular magnetic resonance imaging of activated platelets allows noninvasive detection of early myocarditis in mice." Sci Rep 10(1): 13211.

McFadyen, J. D., J. Zeller, L. A. Potempa, G. A. Pietersz, S. U. Eisenhardt and K. Peter (2020). "C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond." Subcell Biochem 94: 499-520.

McFadyen, J. D., H. Stevens and K. Peter (2020). "The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications." Circ Res 127(4): 571-587.

McFadyen, J. D. and K. Peter (2020). "Transcatheter Aortic Valve Implantation, Atrial Fibrillation, and Bleeding: A Surprisingly Fatal Attraction." Thromb Haemost 120(11): 1479-1482.

Siegel, P. M., J. Schmich, G. Barinov, I. Bojti, C. Vedecnik, N. R. Simanjuntak, C. Bode, M. Moser, K. Peter and P. Diehl (2020). "Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia?" J Thromb Thrombolysis 50(3): 533-542.

Stevens, H., K. Peter, H. Tran and J. McFadyen (2020). "Predicting the Risk of Recurrent Venous Thromboembolism: Current Challenges and Future Opportunities." J Clin Med 9(5).

Thurgood, P., S. A. Suarez, E. Pirogova, A. R. Jex, K. Peter, S. Baratchi and K. Khoshmanesh (2020). "Tunable Harmonic Flow Patterns in Microfluidic Systems through Simple Tube Oscillation." Small 16(43): e2003612.

Walker, J. A., X. Wang, K. Peter, K. Kempe and S. R. Corrie (2020). "Dynamic Solid-State Ultrasound Contrast Agent for Monitoring pH Fluctuations In Vivo." ACS Sens 5(4): 1190-1197.

Wang, X., S. Temme, C. Grapentin, J. Palasubramaniam, A. Walsh, W. Kramer, P. Kleimann, A. Havlas, R. Schubert, J. Schrader, U. Flogel and K. Peter (2020). "Fluorine-19 Magnetic Resonance Imaging of Activated Platelets." J Am Heart Assoc 9(18): e016971.

Wang, X., M. Ziegler, J. McFadyen and K. Peter (2020). Molecular Imaging of Arterial and Venous Thrombosis, Preprints.

Zaldivia, M. T. K., D. Hering, P. Marusic, Y. Sata, R. Lee, M. D. Esler, N. M. Htun, J. Duval, L. Hammond, U. Flierl, X. Wang, G. R. Drummond, A. Walton, E. E. Gardiner, R. K. Andrews, M. P. Schlaich and K. Peter (2020). "Successful renal denervation decreases the platelet activation status in hypertensive patients." Cardiovasc Res 116(1): 202-210.

Zia, A., Y. Wu, T. Nguyen, X. Wang, K. Peter and H. T. Ta (2020). "The choice of targets and ligands for site-specific delivery of nanomedicine to atherosclerosis." Cardiovasc Res 116(13): 2055-2068.

Ziegler, M., M. Wallert, S. Lorkowski and K. Peter (2020). "Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy?" Antioxidants (Basel) 9(10): 935.

Abraham, M. K., E. Jost, J. D. Hohmann, A. K. Searle, V. Bongcaron, Y. Song, H. P. Wendel, K. Peter, S. Krajewski and X. Wang (2021). "A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices." Pharmaceutics 13(9): 1504.

Adao, R., P. R. Stoddart and K. Peter (2021). "Avalanching nanoparticles bring new light to cardiovascular imaging." Cardiovasc Res 117(5): e60-e63.

Fernando, H., Z. Nehme, K. Peter, S. Bernard, M. Stephenson, J. E. Bray, P. S. Myles, R. Stub, P. Cameron, A. H. Ellims, A. J. Taylor, D. M. Kaye, K. Smith and D. Stub (2021). "Association between pre-hospital chest pain severity and myocardial injury in ST elevation myocardial infarction: A post-hoc analysis of the AVOID study." Int J Cardiol Heart Vasc 37: 100899.

Fernando, H., T. Duong, K. Huynh, J. Noonan, J. Shaw, S. J. Duffy, Z. Nehme, K. Smith, P. S. Myles, P. J. Meikle, K. Peter and D. Stub (2021). "Effects of lignocaine vs. opioids on antiplatelet activity of ticagrelor: the LOCAL trial." Eur Heart J 42(39): 4025-4036.

Fernando, H., J. A. Shaw, P. S. Myles, K. Peter and D. Stub (2021). "The opioid-P2Y12 inhibitor interaction: Potential strategies to mitigate the interaction and consideration of alternative analgesic agents in myocardial infarction." Pharmacol Ther 217: 107665.

Fernando, H., D. Dinh, S. J. Duffy, A. Brennan, A. Sharma, D. Clark, A. Ajani, M. Freeman, K. Peter, D. Stub, C. Hiew, C. M. Reid and E. Oqueli (2021). "Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry." Int J Cardiol Heart Vasc 33: 100745.

Fernando, H., S. J. Duffy, A. Low, D. Dinh, N. Adrianopoulos, A. Sharma, K. Peter, D. Stub, K. Leong, A. Ajani, D. Clark, M. Freeman, M. Sebastian, A. Brennan, L. Selkrig, C. M. Reid, D. Kaye and E. Oqueli (2021). "Totally Occluded Culprit Coronary Artery in Patients with Non-ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention." Am J Cardiol 156: 52-57.

Flögel, U., S. Temme, C. Jacoby, T. Oerther, P. Keul, V. Flocke, X. Wang, F. Bönner, F. Nienhaus, K. Peter, J. Schrader, M. Grandoch, M. Kelm and B. Levkau (2021). "Multi-targeted (1)H/(19)F MRI unmasks specific danger patterns for emerging cardiovascular disorders." Nat Commun 12(1): 5847.

Kather, M. G., J. Zeller, D. Plattner, B. Breit, S. Kreuzaler, G. Krippner, K. Peter, S. U. Eisenhardt and B. Kammerer (2021). "Pharmacokinetic study of the novel phosphocholine derivative 3-dibutylaminopropylphosphonic acid by LC-MS coupling." J Chromatogr B Analyt Technol Biomed Life Sci 1186: 122998.

Kiefer, J., J. Zeller, B. Bogner, I. A. Hörbrand, F. Lang, E. Deiss, O. Winninger, M. Fricke, S. Kreuzaler, E. Smudde, M. Huber-Lang, K. Peter, K. J. Woollard and S. U. Eisenhardt (2021). "An Unbiased Flow Cytometry-Based Approach to Assess Subset-Specific Circulating Monocyte Activation and Cytokine Profile in Whole Blood." Front Immunol 12: 641224.

Koay, Y. C., Y. C. Chen, J. A. Wali, A. W. S. Luk, M. Li, H. Doma, R. Reimark, M. T. K. Zaldivia, H. T. Habtom, A. E. Franks, G. Fusco-Allison, J. Yang, A. Holmes, S. J. Simpson, K. Peter and J. F. O'Sullivan (2021). "Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability." Cardiovasc Res 117(2): 435-449.

Kott, K. A., M. C. Morel-Kopp, S. T. Vernon, Y. Takagi, B. A. Di Bartolo, K. Peter, J. Y. Yang, S. M. Grieve, C. Ward and G. A. Figtree (2021). "Association of Global Coagulation Profiles With Cardiovascular Risk Factors and Atherosclerosis: A Sex Disaggregated Analysis From the BioHEART-CT Study." J Am Heart Assoc 10(20): e020604.

Kyaw, T., P. Loveland, P. Kanellakis, A. Cao, A. Kallies, A. L. Huang, K. Peter, B. H. Toh and A. Bobik (2021). "Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms." Eur Heart J 42(9): 938-947.

Lai, A., Y. C. Chen, C. D. Cox, A. Jaworowski, K. Peter and S. Baratchi (2021). "Analyzing the shear-induced sensitization of mechanosensitive ion channel Piezo-1 in human aortic endothelial cells." J Cell Physiol 236(4): 2976-2987.

Lai, A., C. D. Cox, N. Chandra Sekar, P. Thurgood, A. Jaworowski, K. Peter and S. Baratchi (2021). "Mechanosensing by Piezo1 and its implications for physiology and various pathologies." Biol Rev Camb Philos Soc.

McFadyen, J. D. and K. Peter (2021). "The known knowns and known unknowns of vaccine-induced thrombotic thrombocytopaenia." Cardiovasc Res 117(11): e147-e150.

McFadyen, J. D. and K. Peter (2021). "Not All Thrombi Are Created Equal: Understanding Thrombus Structure on the Time-Space Continuum." Thromb Haemost.

McFadyen, J. D. and K. Peter (2021). "Platelet CXCL14: introducing a new player and potential therapeutic target in thromboinflammation." Cardiovasc Res 117(3): 645-647.

Moon, M. J. and K. Peter (2021). "MicroRNAs as Biomarkers for Personalized Antiplatelet Therapy." Thromb Haemost 121(9): 1121.

Nguyen, N., P. Thurgood, N. C. Sekar, S. Chen, E. Pirogova, K. Peter, S. Baratchi and K. Khoshmanesh (2021). "Microfluidic models of the human circulatory system: versatile platforms for exploring mechanobiology and disease modeling." Biophys Rev 13(5): 769-786.

Nguyen, P. C., H. Stevens, K. Peter and J. D. McFadyen (2021). "Submassive Pulmonary Embolism: Current Perspectives and Future Directions." J Clin Med 10(15).

Orian, J. M., C. S. D'Souza, P. Kocovski, G. Krippner, M. W. Hale, X. Wang and K. Peter (2021). "Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy." Front Immunol 12: 620963.

Pereira, M., N. T. Lee, J. Noonan, A. E. H. Willcox, I. Calvello, S. R. Georgy, C. Selan, J. S. Chia, W. Hauw, X. Wang, K. Peter, S. C. Robson, H. H. Nandurkar and M. Sashindranath (2021). "Early Endothelial Activation in a Mouse Model of Graft vs Host Disease Following Chemotherapy." Front Immunol 12: 708554.

Rahman, M. M., N. Garcia, Y. S. Loh, D. C. Marks, I. Banakh, P. Jagadeesan, N. R. Cameron, C. Yung-Chih, M. Costa, K. Peter, H. Cleland and S. Akbarzadeh (2021). "A platelet-derived hydrogel improves neovascularisation in full thickness wounds." Acta Biomater 136: 199-209.

Refaat, A., B. Del Rosal, J. Palasubramaniam, G. Pietersz, X. Wang, S. E. Moulton and K. Peter (2021). "Near-infrared light-responsive liposomes for protein delivery: Towards bleeding-free photothermally-assisted thrombolysis." J Control Release 337: 212-223.

Refaat, A., B. del Rosal, J. Palasubramaniam, G. Pietersz, X. Wang, K. Peter and S. E. Moulton (2021). "Smart Delivery of Plasminogen Activators for Efficient Thrombolysis; Recent Trends and Future Perspectives." Advanced Therapeutics 4(6): 2100047.

Rocca, B. and K. Peter (2021). "Platelets, coagulation, and the vascular wall: the quest to better understand and smarten up our therapeutic targeting of this triad in primary and secondary prevention of cardiovascular events." Cardiovasc Res 117(9): 1998-2000.

Schmidt, S. N., W. Reichardt, B. A. Kaufmann, C. Wadle, D. von Elverfeldt, P. Stachon, I. Hilgendorf, D. Wolf, T. Heidt, D. Duerschmied, K. Peter, C. Bode, C. von Zur Mühlen and A. Maier (2021). "P2Y(12) Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection Fraction." Cells 10(12).

Siegel, P. M., I. Bojti, N. Bassler, J. Holien, U. Flierl, X. Wang, P. Waggershauser, X. Tonnar, C. Vedecnik, C. Lamprecht, I. Stankova, T. Li, T. Helbing, D. Wolf, N. Anto-Michel, L. S. Mitre, J. Ehrlich, L. Orlean, I. Bender, A. Przewosnik, M. Mauler, L. Hollederer, M. Moser, C. Bode, M. W. Parker, K. Peter and P. Diehl (2021). "A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarction." Basic Res Cardiol 116(1): 17.

Siegel, P. M., L. Orlean, I. Bojti, K. Kaier, T. Witsch, J. S. Esser, G. Trummer, M. Moser, K. Peter, C. Bode and P. Diehl (2021). "Monocyte Dysfunction Detected by the Designed Ankyrin Repeat Protein F7 Predicts Mortality in Patients Receiving Veno-Arterial Extracorporeal Membrane Oxygenation." Front Cardiovasc Med 8: 689218.

Siegel, P. M., L. Sander, A. Fricke, J. Stamm, X. Wang, P. Sharma, N. Bassler, Y. L. Ying, C. B. Olivier, S. U. Eisenhardt, C. Bode, I. Ahrens, P. Diehl and K. Peter (2021). "P(2)Y(12) receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells." Sci Rep 11(1): 17459.

Thurgood, P., G. Concilia, N. Tran, N. Nguyen, A. J. Hawke, E. Pirogova, A. R. Jex, K. Peter, S. Baratchi and K. Khoshmanesh (2021). "Generation of programmable dynamic flow patterns in microfluidics using audio signals." Lab Chip 21(23): 4672-4684.

Walsh, A. P. G., H. N. Gordon, K. Peter and X. Wang (2021). "Ultrasonic particles: An approach for targeted gene delivery." Adv Drug Deliv Rev 179: 113998.

Zeller, J., B. Bogner, J. Kiefer, D. Braig, O. Winninger, M. Fricke, E. Karasu, K. Peter, M. Huber-Lang and S. U. Eisenhardt (2021). "CRP Enhances the Innate Killing Mechanisms Phagocytosis and ROS Formation in a Conformation and Complement-Dependent Manner." Front Immunol 12: 721887.

Ardipradja, K. S., C. W. Wichmann, K. Hickson, A. Rigopoulos, K. M. Alt, H. A. Pearce, X. Wang, G. O'Keefe, A. M. Scott, K. Peter, C. E. Hagemeyer and U. Ackermann (2022). "(18)F Site-Specific Labelling of a Single-Chain Antibody against Activated Platelets for the Detection of Acute Thrombosis in Positron Emission Tomography." Int J Mol Sci 23(13).

Brassington, K., P. Kanellakis, A. Cao, B. H. Toh, K. Peter, A. Bobik and T. Kyaw (2022). "Crosstalk between cytotoxic CD8+ T cells and stressed cardiomyocytes triggers development of interstitial cardiac fibrosis in hypertensive mouse hearts." Front Immunol 13: 1040233.

Dayawansa, N. H., S. Baratchi and K. Peter (2022). "Uncoupling the Vicious Cycle of Mechanical Stress and Inflammation in Calcific Aortic Valve Disease." Front Cardiovasc Med 9: 783543.

Dix, C., J. Zeller, H. Stevens, S. U. Eisenhardt, K. Shing, T. L. Nero, C. J. Morton, M. W. Parker, K. Peter and J. D. McFadyen (2022). "C-reactive protein, immunothrombosis and venous thromboembolism." Front Immunol 13: 1002652.

Fernando, H., Z. Nehme, D. Dinh, E. Andrew, A. Brennan, W. Shi, J. Bloom, S. J. Duffy, J. Shaw, K. Peter, V. Nadurata, W. Chan, J. Layland, M. Freeman, W. Van Gaal, S. Bernard, J. Lefkovits, D. Liew, M. Stephenson, K. Smith and D. Stub (2022). "Impact of prehospital opioid dose on angiographic and clinical outcomes in acute coronary syndromes." Emerg Med J.

Fernando, H., Z. Nehme, C. Milne, J. O'Brien, S. Bernard, M. Stephenson, P. S. Myles, J. Lefkovits, K. Peter, A. Brennan, D. Dinh, E. Andrew, A. J. Taylor, K. Smith and D. Stub (2022). "LidocAine Versus Opioids In MyocarDial infarction: The AVOID-2 randomised controlled trial." Eur Heart J Acute Cardiovasc Care.

Fernando, H., J. D. McFadyen, X. Wang, J. Shaw, D. Stub and K. Peter (2022). "P2Y(12) Antagonists in Cardiovascular Disease-Finding the Best Balance Between Preventing Ischemic Events and Causing Bleeding." Front Cardiovasc Med 9: 854813.

Figtree, G. A., P. D. Adamson, C. Antoniades, R. S. Blumenthal, M. Blaha, M. Budoff, D. S. Celermajer, M. Y. Chan, C. K. Chow, D. Dey, G. Dwivedi, N. Giannotti, S. M. Grieve, C. Hamilton-Craig, B. A. Kingwell, J. C. Kovacic, J. K. Min, D. E. Newby, S. Patel, K. Peter, P. J. Psaltis, S. T. Vernon, D. T. Wong and S. J. Nicholls (2022). "Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development." Circulation 146(22): 1712-1727.

Lai, A., C. D. Cox, N. Chandra Sekar, P. Thurgood, A. Jaworowski, K. Peter and S. Baratchi (2022). "Mechanosensing by Piezo1 and its implications for physiology and various pathologies." Biol Rev Camb Philos Soc 97(2): 604-614.

Lai, A., P. Thurgood, C. D. Cox, C. Chheang, K. Peter, A. Jaworowski, K. Khoshmanesh and S. Baratchi (2022). "Piezo1 Response to Shear Stress Is Controlled by the Components of the Extracellular Matrix." ACS Appl Mater Interfaces 14(36): 40559-40568.

Li, J., S. Thiele, R. W. Kirk, B. C. Quirk, A. Hoogendoorn, Y. C. Chen, K. Peter, S. J. Nicholls, J. W. Verjans, P. J. Psaltis, C. Bursill, A. M. Herkommer, H. Giessen and R. A. McLaughlin (2022). "3D-Printed Micro Lens-in-Lens for In Vivo Multimodal Microendoscopy." Small: e2107032.

Li, J., N. J. Montarello, A. Hoogendoorn, J. W. Verjans, C. A. Bursill, K. Peter, S. J. Nicholls, R. A. McLaughlin and P. J. Psaltis (2022). "Multimodality Intravascular Imaging of High-Risk Coronary Plaque." JACC Cardiovasc Imaging 15(1): 145-159.

Liu, M., Y. Cai, J. Pan, K. Peter and Z. Li (2022). "Macrophage polarization as a potential therapeutic target for atherosclerosis: a dynamic stochastic modelling study." R Soc Open Sci 9(8): 220239.

Liu, H., G. Pietersz, K. Peter and X. Wang (2022). "Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis." J Nanobiotechnology 20(1): 75.

McFadyen, J. D., P. Sharma, M. J. Moon, J. Noonan, E. Goodall, H. A. Tran and K. Peter (2022). "Activation of circulating platelets in vaccine-induced thrombotic thrombocytopenia and its reversal by intravenous immunoglobulin." Br J Haematol 196(1): 234-237.

McFadyen, J. D. and K. Peter (2022). "Not All Thrombi Are Created Equal: Understanding Thrombus Structure on the Time-Space Continuum." Thromb Haemost 122(3): 315.

McFadyen, J. D., P. H. Mangin and K. Peter (2022). "Of Mice and Man: The Unwinding of CLEC-2 as an Antithrombotic Target?" Thromb Haemost.

Mehta, S., V. Bongcaron, T. K. Nguyen, Y. Jirwanka, A. Maluenda, A. P. G. Walsh, J. Palasubramaniam, M. D. Hulett, R. Srivastava, A. Bobik, X. Wang and K. Peter (2022). "An Ultrasound-Responsive Theranostic Cyclodextrin-Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis." Small: e2200967.

Moon, M. J., J. D. McFadyen and K. Peter (2022). "Caught at the Scene of the Crime: Platelets and Neutrophils Are Conspirators in Thrombosis." Arterioscler Thromb Vasc Biol 42(1): 63-66.

Nan Tie, E., H. Fernando, Z. Nehme, D. Dinh, E. Andrew, A. Brennan, S. Zaman, D. Liew, M. Stephenson, J. Lefkovits, K. Peter, S. J. Duffy, J. Shaw, K. Smith and D. Stub (2022). "Sex differences in prehospital analgesia in patients presenting with acute coronary syndromes and their association with clinical outcomes." Catheter Cardiovasc Interv: 1-7.

Noaman, S., C. Neil, J. O'Brien, M. Frenneaux, J. Hare, B. Wang, T. Yee Tai, J. Theuerle, J. Shaw, D. Stub, J. Bloom, A. Walton, S. J. Duffy, K. H. Peter, N. Cox, D. M. Kaye, A. Taylor and W. Chan (2022). "UpStreAm doxycycline in ST-eLeVation myocArdial infarction - targetinG infarct hEaling and ModulatIon (SALVAGE-MI trial)." Eur Heart J Acute Cardiovasc Care.

Noonan, J., A. Bobik and K. Peter (2022). "The tandem stenosis mouse model: Towards understanding, imaging, and preventing atherosclerotic plaque instability and rupture." Br J Pharmacol 179(5): 979-997.

Refaat, A., M. L. Yap, G. Pietersz, A. P. G. Walsh, J. Zeller, B. Del Rosal, X. Wang and K. Peter (2022). "In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications." J Nanobiotechnology 20(1): 450.

Sahle, B. W., D. Pilcher, E. Litton, R. Ofori-Asenso, K. Peter, J. McFadyen and T. Bucknall (2022). "Association between frailty, delirium, and mortality in older critically ill patients: a binational registry study." Ann Intensive Care 12(1): 108.

Sahle, B. W., D. Pilcher, K. Peter, J. D. McFadyen and T. Bucknall (2022). "Trends and risk factors for omission of early thromboprophylaxis in Australian and New Zealand ICUs between 2009 and 2020." Intensive Care Med 48(5): 590-598.

Searle, A. K., Y. C. Chen, M. Wallert, J. D. McFadyen, A. C. Maluenda, J. Noonan, P. Kanellakis, M. T. K. Zaldivia, A. Huang, H. Lioe, M. Biondo, M. W. Nolte, P. Rossato, A. Bobik, C. Panousis, X. Wang, H. Hosseini and K. Peter (2022). "Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques." Thromb Haemost 122(2): 196-207.

Siegel, P. M., A. S. Przewosnik, J. Wrobel, T. Heidt, M. Moser, K. Peter, C. Bode, P. Diehl and I. Bojti (2022). "An activation specific anti-Mac-1 designed ankyrin repeat protein improves survival in a mouse model of acute lung injury." Sci Rep 12(1): 6296.

Stevens, H., R. Canovas, H. Tran, K. Peter and J. D. McFadyen (2022). "Inherited Thrombophilias Are Associated With a Higher Risk of COVID-19-Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study." Circulation 145(12): 940-942.

Thurgood, P., C. Chheang, S. Needham, E. Pirogova, K. Peter, S. Baratchi and K. Khoshmanesh (2022). "Generation of dynamic vortices in a microfluidic system incorporating stenosis barrier by tube oscillation." Lab Chip.

Watson, A. M. D., Y. C. Chen and K. Peter (2022). "Vascular Aging and Vascular Disease Have Much in Common!" Arterioscler Thromb Vasc Biol 42(8): 1077-1080.

Zeller, J., K. S. Cheung Tung Shing, T. L. Nero, J. D. McFadyen, G. Krippner, B. Bogner, S. Kreuzaler, J. Kiefer, V. K. Horner, D. Braig, H. Danish, S. Baratchi, M. Fricke, X. Wang, M. G. Kather, B. Kammerer, K. J. Woollard, P. Sharma, C. J. Morton, G. Pietersz, M. W. Parker, K. Peter and S. U. Eisenhardt (2022). "A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein." EMBO Mol Med: e16236.

Bojti, I., Q. Wang, T. Bojti, F. Bojti, P. M. Siegel, T. Heidt, M. Moser, C. Bode, D. Westermann, K. Peter and P. Diehl (2023). "An Activation-Specific Anti-Mac-1 Designed-Ankyrin-Repeat-Protein Attenuates Colitis in Mice." Life (Basel) 13(7).

Chandra Sekar, N., S. Aguilera Suarez, N. Nguyen, A. Lai, P. Thurgood, Y. Zhou, C. Chheang, S. Needham, E. Pirogova, K. Peter, K. Khoshmanesh and S. Baratchi (2023). "Studying the Synergistic Effect of Substrate Stiffness and Cyclic Stretch Level on Endothelial Cells Using an Elastomeric Cell Culture Chamber." ACS Appl Mater Interfaces 15(4): 4863-4872.

Chen, Y. C., M. Smith, Y. L. Ying, M. Makridakis, J. Noonan, P. Kanellakis, A. Rai, A. Salim, A. Murphy, A. Bobik, A. Vlahou, D. W. Greening and K. Peter (2023). "Quantitative proteomic landscape of unstable atherosclerosis identifies molecular signatures and therapeutic targets for plaque stabilization." Commun Biol 6(1): 265.

Fernando, H., Z. Nehme, D. Dinh, E. Andrew, A. Brennan, W. Shi, J. Bloom, S. J. Duffy, J. Shaw, K. Peter, V. Nadurata, W. Chan, J. Layland, M. Freeman, W. Van Gaal, S. Bernard, J. Lefkovits, D. Liew, M. Stephenson, K. Smith and D. Stub (2023). "Impact of prehospital opioid dose on angiographic and clinical outcomes in acute coronary syndromes." Emerg Med J 40(2): 101-107.

Fernando, H., Z. Nehme, C. Milne, J. O'Brien, S. Bernard, M. Stephenson, P. S. Myles, J. Lefkovits, K. Peter, A. Brennan, D. Dinh, E. Andrew, A. J. Taylor, K. Smith and D. Stub (2023). "LidocAine Versus Opioids In MyocarDial infarction: the AVOID-2 randomized controlled trial." Eur Heart J Acute Cardiovasc Care 12(1): 2-11.

Garcia, N., M. M. Rahman, C. L. Arellano, I. Banakh, C. Yung-Chih, K. Peter, H. Cleland, C. H. Lo and S. Akbarzadeh (2023). "Graft-Host Interaction and Its Effect on Wound Repair Using Mouse Models." International Journal of Molecular Sciences 24(22): 16277.

Jaimes Campos, M. A., I. Andújar, F. Keller, G. Mayer, P. Rossing, J. A. Staessen, C. Delles, J. Beige, G. Glorieux, A. L. Clark, W. Mullen, J. P. Schanstra, A. Vlahou, K. Rossing, K. Peter, A. Ortiz, A. Campbell, F. Persson, A. Latosinska, H. Mischak, J. Siwy and J. Jankowski (2023). "Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study." Pharmaceuticals (Basel) 16(9).

Jenkins, A., K. Peter and G. Kilov (2023). "Managing atherosclerotic risk in type 1 diabetes." Endocrinology Today 12(4): 28-33.

Kyaw, T., G. Drummond, A. Bobik and K. Peter (2023). "Myocarditis: causes, mechanisms, and evolving therapies." Expert Opin Ther Targets: 1-14.

Noaman, S., C. Neil, J. O'Brien, M. Frenneaux, J. Hare, B. Wang, T. Yee Tai, J. Theuerle, J. Shaw, D. Stub, J. Bloom, A. Walton, S. J. Duffy, K. H. Peter, N. Cox, D. M. Kaye, A. Taylor and W. Chan (2023). "UpStreAm doxycycline in ST-eLeVation myocArdial infarction: targetinG infarct hEaling and ModulatIon (SALVAGE-MI trial)." Eur Heart J Acute Cardiovasc Care 12(3): 143-152.

Refaat, A., B. del Rosal, V. Bongcaron, A. P. G. Walsh, G. Pietersz, K. Peter, S. E. Moulton and X. Wang (2023). "Activated Platelet-Targeted IR780 Immunoliposomes for Photothermal Thrombolysis." Advanced Functional Materials 33(4): 2209019.

Sahle, B. W., D. Pilcher, K. Peter, J. D. McFadyen, E. Litton and T. Bucknall (2023). "Mortality data from omission of early thromboprophylaxis in critically ill patients highlights the importance of an individualised diagnosis-related approach." Thromb J 21(1): 59.

Schwarz, N., S. Fernando, Y. C. Chen, T. Salagaras, S. R. Rao, S. Liyanage, A. E. Williamson, D. Toledo-Flores, C. Dimasi, T. J. Sargeant, J. Manavis, E. Eddy, P. Kanellakis, P. L. Thompson, J. T. M. Tan, M. F. Snel, C. A. Bursill, S. J. Nicholls, K. Peter and P. J. Psaltis (2023). "Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation." Faseb j 37(4): e22846.

Stevens, H., S. Ruiz-Carmona, K. Peter and J. McFadyen (2023). "COVID-19 thromboembolism is reduced in ambulatory, but not hospitalized patients, following COVID-19 vaccination Short title: COVID-19 thromboembolism." Haematologica.

Stevens, H., H. Bortz, S. Chao, R. Ramanan, W. Clements, K. Peter, J. D. McFadyen and H. Tran (2023). "Improving the rate of inferior vena cava filter retrieval through multidisciplinary engagement." Res Pract Thromb Haemost 7(1): 100040.

Thurgood, P., S. Needham, E. Pirogova, K. Peter, S. Baratchi and K. Khoshmanesh (2023). "Dynamic Vortex Generation, Pulsed Injection, and Rapid Mixing of Blood Samples in Microfluidics Using the Tube Oscillation Mechanism." Anal Chem 95(5): 3089-3097.

Thurgood, P., A. Hawke, L. S. Low, A. Borg, K. Peter, S. Baratchi and K. Khoshmanesh (2023). "Tube Oscillation Drives Transitory Vortices Across Microfluidic Barriers." Small Methods: e2301427.

Vazquez-Prada, K. X., S. S. Moonshi, Y. Wu, F. Akther, B. W. C. Tse, K. A. Sokolowski, K. Peter, X. Wang, G. Xu and H. T. Ta (2023). "A Spiky Silver-Iron Oxide Nanoparticle for Highly Efficient Targeted Photothermal Therapy and Multimodal Imaging of Thrombosis." Small 19(11): e2205744.

Walsh, A. P. G., E. Yu, J. D. McFadyen, V. Bongcaron, M. J. Moon, A. Huang, J. F. Arthur, I. L. Muir, V. Rayzman, C. Panousis, X. Wang and K. Peter (2023). "Activated Coagulation FXII: A Unique Target for In Vivo Molecular Imaging." Arterioscler Thromb Vasc Biol 43(6): 1031-1040.

Wei, D., J. D. Melgarejo, L. Van Aelst, T. Vanassche, P. Verhamme, S. Janssens, K. Peter and Z.-Y. Zhang (2023). "Prediction of Coronary Artery Disease Using Urinary Proteomics." European Journal of Preventive Cardiology.

Zeller, J., K. Peter and S. U. Eisenhardt (2024). "Intravital Imaging of Leukocyte-Endothelial Interaction in Hindlimb Ischemia/Reperfusion Injury by Intravital Multiphoton Microscopy." Methods Mol Biol 2711: 89-104.

Research Publications

Wolf D, Michel NA, Blankenbach H, Wiedemann A, Buscher K, Hohmann JD, Lim B, Bäuml M, Marki A, Mauler M, Duerschmied D, Fan Z, Winkels H, Sidler D, Diehl P, Zajonc D, Hilgendorf, Stachon P, Marchini T, Willecke F, Schell M, Sommer B, von zur Muhlen C, Reinöhl J, Gerhardt T, Plow EF, Yakubenko V, Libby P, Bode C, Ley K, Peter K*, Andreas Zirlik.* A ligand-specific blockade of the integrin Mac-1 selectivity targets pathologic inflammation while maintaining protective host-defense. Nature Communications 2018; 9: 525. *equally contributing senior authors.

Baratchi S, Zaldivia MTK, Wallert M, Loseff-Silver J, Al-Aryahi S, Zamani J, Thurgood P, Htun NM, Stu D, Duffy SJ, Walton A, Nguyen H, Jaworowski A, Khoshmanesh K, Peter K. TAVI represents an anti-inflammatory therapy via reduction of shear-stress induced, Piezo-1-mediated monocyte activation. Circulation 2020 [In press].

McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circulation Research 2020 [In press].